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ABSTRACT
Four separate studies were conducted to examine carnosine levels and associated
antioxidant activity in poultry co-products, in rendered poultry protein meal, in tissues
from stressed or non-stressed chickens. In the first study, carnosine was extracted from
poultry co-products (head, liver, lungs, tail, gizzard, brain and heart). Liver contained the
highest (102.29 mg/gm) level, while brain contained the lowest level of carnosine (0.95
mg/gm) (p ≤ 0.05).

Except brain, all tissue ultrafiltrates (20.87-39.57%) and

reconstituted dry powders (5.66- 14.47%) showed thiobarbituric reactive acid species
(TBARS) inhibition. Head ultrafiltrate and reconstituted dry powder showed maximum
while gizzard showed the minimum metal chelating activity (p ≤ 0.05). Free radical
scavenging activity of ultrafiltrate of all tissues samples ranged from 25.1 to 79.4% while
this activity was higher (29.8 to 84.1%) in the reconstituted dry powder of all tissue
samples.

Oxygen radical absorbing capacity (ORAC) values were highest in liver

ultrafiltrate and lowest in heart (p ≤ 0.05). Results indicated that carnosine was present in
all the tissue samples investigated and their ultrafiltrates as well as dry powders of tissue
samples possess antioxidant properties.
In the second study examining poultry protein meal, carnosine content of sampleG was almost 2.6 times higher than sample–A. TBARS inhibition by sample-G was
15.9% while Sample-A did not exhibit any TBARS inhibition. Metal chelating activity
and free radical scavenging activities of sample-A and sample-G did not differ. ORAC
values (µM Trolox Equivalents /gm of dry sample) of sample-A (84.4) were greater than
sample-G (68.4) (p≤0.05).
ii

The third study determined carnosine levels in different tissues of broilers under
stress versus non-stress conditions. Corticosterone levels of stressed broilers (24.36
ng/ml) was 10 fold higher (p=0.002) than non-stressed broilers (2.28 ng/ml). There was
significant increase in carnosine content in breast tissue of stressed birds (17.39 mg/gm),
and was 10 times (p=0.005) more than non-stressed birds (1.85 mg/gm). Carnosine
content in thigh of stressed birds (21.25 mg/gm) was approximately 2 fold higher
(p=0.001) than non-stressed birds (11.10 mg/gm). Carnosine content in brain of stressed
birds did not differ (p=0.82) from that in non-stressed birds. Results indicated that
carnosine may play a significant role in muscles during short term stress.
In fourth study, it was determined that TBARS inhibition and metal chelating
activity of carnosine was due to the imidazole ring present in the histidine while free
radical scavenging activity of carnosine was attributed to histidine amino acid.
Overall, conclusions were drawn that poultry byproducts, poultry protein meal
contains carnosine and exhibited antioxidant properties. These antioxidant properties
were due to carnosine’s unique structure. Lastly, stress increases the carnosine levels in
breast and thigh tissues of broilers.
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CHAPTER ONE
INTRODUCTION
Oxidation in foods is a major concern in food deterioration affecting lipids,
proteins and carbohydrates. However, oxidation of lipids is the main cause of oxidative
deterioration of food leading to loss of sensory and nutritional quality. Oxidation may
also form toxic compounds which could pose potential health concerns, such as
atherosclerosis, cytotoxicity, and carcinogenesis. Therefore, preventing oxidation of food
is critical to increasing shelf life and maintaining the quality of foods.
Oxidation of lipids is a chain reaction which can be depicted in three steps;
initiation, propagation and termination. Antioxidants are substances added to food to
retard the rate of the oxidation reaction primarily during initiation and to a lesser extent
propagation. While antioxidants can inhibit oxidation in several ways, “true antioxidants”
act by inhibiting the chain reaction:
ROO. + AH

ROOH + A.

Food antioxidants can be categorized as either natural or synthetic. Tocopherols,
ascorbic acid, polyphenols and quercetin are the examples of natural antioxidants, while
butylated hydroxy anisole (BHA), butylated hydroxy toluene (BHT ), propyl gallate (PG)
and tert butyl hydroquinone (TBHQ) are synthetic antioxidants. Synthetic antioxidants
are strictly regulated by the Food and Drug Administration (FDA), due to lingering
concerns about their toxicity above certain limits.
Due to the positive perception of natural foods and positive health implications
for antioxidants, numerous research studies are being conducted to identify natural
1

antioxidants from different sources and to minimize the use of synthetic antioxidants and
to enhance the nutritional quality of food. There is interest in carnosine as a natural
antioxidant for the food industry, especially since there are no reports of toxic effects of
carnosine since its derivatives and excess of dietary carnosine is excreted in urine. Since
its discovery in 1900 by Guelwitsch from beef extract, carnosine has been extracted from
a variety of animal tissues. Researchers have also sought to better understand the
significance of carnosine in the human body. Carnosine has been identified as a
neurotransmitter, buffer in the skeletal muscle, aid in muscle contraction, regulator of
cardiac muscle proteins, anti-ageing factor and a potent skeletal muscle antioxidant.
Carnosine exhibits multiple antioxidant properties such as metal chelation, reactive
oxygen scavenging, free radical scavenging and peroxide decomposition. With multiple
modes of antioxidant activity in foods and in the body there is keen interest in the
scientific community in carnosine.
In the US, 100 million hogs, 35 million cattle and 8.7 billion chickens are
processed annually. Foury nine percent live weight of cattle, 44% live weight of hogs,
37% live weight of poultry and 57% live weight of the fish products are not used for
human consumption. The unprocessed or underutilized products of the food or animal
industry could pose a serious hazard to the environment, humans and animals, if not
handled properly. The rendering industry processes these inedible products producing
valuable by-products. Presently, in the United States (US), there are approximately 300
rendering plants processing about 100 million pounds of meat industry waste every day,
resulting in total production of 54 billion pounds processed co-products annually.
2

In 2009, 8.7 billion chickens were slaughtered in the US resulting in production of
1.16 million metric tons of poultry byproduct meal, 0.6 million metric tons of poultry fat
and 0.5 million metric tons of feather meal (Swisher, 2009). At present, most poultry byproducts are being utilized by the rendering industry to produce poultry by-product meal
and fat.

Carnosine has already been extracted from low value products such as

mechanically deboned pork and from isolated muscle protein waste material.
Therefore, the objectives of the present research were:
1. To determine the carnosine content in poultry by-products and to measure its
antioxidant properties
2. To determine the carnosine content in poultry protein meal and to measure its
antioxidant properties.
3. To compare carnosine antioxidant activity with its constituent amino acids, βalanine and L-histidine as well as with imidazole.
4.

To compare carnosine levels recovered from breast, thigh and brain tissues of
broilers previously exposed to short term or non-stress conditions.

One potential of this research would be the recovery of carnosine from poultry coproducts prior to rendering. If 3.4 billion pounds poultry by-products are considered as
raw material for carnosine recovery, without considering organic nature and purity, it can
be estimated that approximately $3.07 million income could be generated by extracting
carnosine from these poultry by-products. Therefore, the overall objective was to extract

3

carnosine using a single step water extraction procedure, with the ultimate goal of
potentially increasing the revenue of the poultry processing and/or rendering industry.
Carnosine has numerous medicinal and therapeutic applications as well as
antioxidant properties in the body. It has been reported that oral intake of carnosine
improves high intensity exercise performance and endurance, facilitates wound healing,
inhibits inflammation and has anti-ulcer effects due to membrane protection activity.
Commercially, this dipeptide is being used as a therapeutic drug and in making antiageing skin lotions. However our primary aim was its application in animal food and as a
therapeutic agent for animals.

4

CHAPTER TWO
LITRATURE REVIEW
2.1.

Introduction
More than a century ago, in 1900, a crystalline substance called carnosine was

isolated from beef muscle extract by Guelwitsch (Guelwitsch 1900, 1906 and 1911).
From systematic analysis, it was found that carnosine is a water soluble dipeptide
composed of β-alanine and histidine. Out of these two amino acids, histidine is an
essential amino acid while β-alanine is a non-essential amino acid synthesized in liver as
a final product of uracil and thymine degradation (Matthews and Traut, 1987).
Since 1900, voluminous research has been conducted studying the sources of
carnosine, its physiological roles and its biochemical importance as well as studies into
carnosine’s therapeutic and medicinal properties.

Properties of Carnosine \

2.2.

Carnosine is soluble in water (one part to 3.2 parts of water at 25°C) while insoluble
in alcohol and most organic solvents, but can be solubilized in some organic solvents to a
certain extent by first dissolving in an aqueous medium and then in organic solvents.
Carnosine is basic in nature and possesses buffering capacity at pH 5.4 to 6.0 (Vigneaud
and Behrens, 1939; Quinn et al., 1992).
Figure 2.1: Carnosine Structure

5

The structure of carnosine is closely tied to its functionality, according to a study
conducted with chicks by Tsuneyoshi et al (2007), Carnosine (β-alanine-L-histidine)
induced hyperactivity in chicks while the reverse structure of carnosine (L-histidine –βalanine)

induced the reverse effect, producing hypnotic and sedative effects in chicks.

The reverse structure of carnosine showed similar results to β-alanine alone. Moreover,
carnosine possesses antioxidant properties due to the imidazole moiety in its structure
(Kohen et al., 1988; Aruoma et al., 1989; Hartman et al., 1990; Quinn et al., 1992;
Vigneaud and Behrens, 1939; Boldyrev et al., 1993; Boldyrev et al., 1997).

2.3.

Biosynthesis of Carnosine
Carnosine is synthesized from β-alanine and histidine by carnosine synthetase [EC

6.3.2.11] (Horinishi et al., 1978). Kalyankar and Meister (1959) found that Mg2+ and
ATP are required for carnosine synthesis. β-alanine, ATP, and carnosine synthetase in the
presence of Mg2+ form a β-alanine-adenylate complex which combines with L-histidine
to produce carnosine.
William and Winnick (1954) studied the physiological site of carnosine and anserine
formation in hatched chicks. They reported that skeletal muscle is the primary tissue for
biosynthesis of both dipeptides while liver does not play any role in carnosine and
anserine formation. Carnosine is methylated to a greater extent than histidine, and invivo as well as in vitro experiments, showed that methylhistidine condenses more readily
with β-alanine than histidine.

6

Biosynthesis of carnosine is restricted to muscle cells, oligodendrocytes, and
ensheathing cells of the olfactory bulb and increases during differentiation of these cells.
Astrocytes, in contrast, do not synthesize carnosine but are equipped with a dipeptide
transporter by which carnosine is taken up very efficiently (Bakardjiev and Bauer, 2000).
A study conducted on rats showed that carnosine is synthesized in gastrocnemius muscle
and not in liver (Tamaki et al., 1980). The half life of carnosine is 29 days and the rate of
carnosine biosynthesis was 0.321 µmol/wet tissue (gm)/day. A similar study by David
Fisher and his colleagues in 1977 on muscle and brain of developing embryos of chicks
(Gallus gallus) found that carnosine levels in muscle of chick embryos were undetectable
until 14 days while at 15 days carnosine levels were detectable < 3μmoles/100 gm and
increased to 22.5 μmoles/100 gm a day after hatching. In contrast, carnosine levels were
less than 3 μmoles/100 gm in brain of a day old chick, indicating that carnosine first
forms in the muscle and then in the brain in chicks (Fisher et al., 1977).

2.4.

Metabolism of Carnosine
Carnosine can be taken orally and can be synthesized in the body. Carnosine is

absorbed maximally in the jejunum in rats which corresponds to the site for active Dglucose uptake and for uptake of most amino acids. Carnosine uptake is Na+ dependent.
In intact mucosal cells, Na+ gradients stimulate peptide transport by producing a proton
gradient via Na+- H+ exchange (Ferraris et al., 1988). Excess of carnosine is excreted in
urine (Perry et al., 1967) and there are no reports of toxic effects of carnosine and its
derivatives (Quinn et al., 1992; Sato et al., 2008) .
7

Carnosine is catabolised into β-alanine and L-histidine by carnosinase (Pegova et al.,
2000). In humans, carnosine is hydrolyzed by two isozymes: tissue (cystolic)
carnosinases [E.C.3.4.13.3] and serum carnosinase [E.C.3.4.13.20] (Scriver and Gibson.,
1995). Guitto et al (2005) stated the carnosinase is not one enzyme but a group of
intracellular and extracellular enzymes belonging to the large family of metalloproteases
which have specific and cystolic non-specific roles. In 2003, Tuefel and his colleagues
reported discovery of two novel genes CN1 and CN2 which are responsible for coding of
metallopeptidases of the M20 family and demonstrated that CN1 corresponds to the
secreted human carnosinases while CN2 is the cystolic non-specific dipeptidase (Teufel
et al., 2003).

2.5.

Regulation of Carnosine Levels
Physiological levels of carnosine are regulated by the activity of carnosine synthetase

(regulates biosynthesis) and carnosinase (regulates metabolism), which are both present
in brain (Quinn et al., 1992; Horinishi et al., 1978). Seely and Marshal (1982) determined
the inhibition of carnosine synthetase by β-alanine analogues {3-aminopropane sulfonic
acid (APS), 5-aminovaleric acid (5-AV), 2-aminoethyl

phosphonic

acid, o-

phosphoethanolamine, nipecotic acid and aminooxyacetic acid} in rat and chick muscle.
Upon isolation of these compounds after injection, they found that APS was most
effective in inhibiting carnosine synthetase in both rat and chick by competitive inhibition
while other analogues showed less inhibitory activity. Synthesis of carnosine could also
be inhibited by 1- methyl histidine and 3- methyl histidine (Horinishi et al., 1978).
8

Carnosine can be metabolized into different derivatives such as anserine and ophidine by
methylation and to acetyl-carnosine by acetylation. The pathways of metabolism of
carnosine have been suggested by various scientists (Begum et al., 2005; Chan and
Decker, 1994; William and Winnick, 1954; Kalyankar and Meister, 1959). The general
pathway of carnosine metabolism is as follows:

9

Carcinine

Histamine

I
β-Alanine
L-Histidine

ATP

Acetyl Carnosine

CS-β-alanine+ AMP+
Pyrophosphate

Acetyl Anserine

III

III

AMP+
CS
Anserine
II
Carnosine

Methyl histidine

II

Ophidine
Carnosinase

Keys
I - Decarboxylation
II -Methylation
III -Acetylation

Figure 2.2: Pathways of Carnosine Biosynthesis and Metabolism.
Keyword: Carnosine Synthetase AMPEC 6.3.2.11= CS
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β-alanine

2.6.

Physiological Functions of Carnosine
Carnosine is responsible for a variety of physiological activities. Review articles have

explained various physiological roles of carnosine in the contraction of muscles (Begum
et al., 2005), as an antioxidant (Chan and Decker., 1994; Guiotto et al., 2005; Marchis et
al., 2000) and as an anti-ageing compound (Stvolinsky and Dobrota, 2000). Protein
carbonylation and accumulation of modified polypeptides causes age associated
phenomenon among cells and tissues and thus could cause atherosclerosis, muscular
dystrophy and neuro degenerative diseases such as Alzheimer’s disease, Parkinson’s
disease. Various pathways of protein carbonylation have been suggested by Aldini et al
(2005). Carnosine acts as anti-ageing compound by quenching or detoxifying cytotoxic
carbonyls such as 4-hydroxy-tran-2, 3,-nonenal (HNR), acrolein (ACR) and
malondialdehyde (advanced lipid oxidation end products) (Aldini et al., 2005). Table 2.1
provides a summary of various physiological functions of carnosine along with a mode
/mechanism of action.

11

Table 2.1: Physiological Functions of Carnosine
S. No. Physiological Function

Mode/ Mechanism of Action

Reference

1.

Facilitates muscle contraction.

(Severin et al.,
1963; Avena
and
Bowen,
1969)

Muscle Contraction

Carnosine activates myosine ATPase.

2.

Potent Buffer in Muscle

pH buffering is main function of
carnosine, in muscle; carnosine and
anserine contribute 40% of the
buffering in the physiological range
(pH 6.5 to 7.5).

(Skulachev,
2000; Davey,
1960; Smith,
1938)

Supplementation of carnosine causes (Abe,
2000;
increased
muscle
carnosine Dunnett
and
concentrations
which
lead
to Harris, 1999)
increased intramuscular hydrogen ion
(H+) buffering capacity.
3.

Neuromodulator

Transmission of nerve impulse.

4.

Putative Neurotransmitter Acts as neurotransmitter.
in brain

5.

Nervous system

(Severin et al.,
1963;
Trombley
et
al., 2000)
(Trombley et
al., 2000 ;
Tomonaga et
al.,
2004;
Tomonaga et
al.,
2005;
Bonfanti et al.,
1999)

Carnosine protects neurons against (Boldyrev
oxidative stress produced due to ROS al., 1999)
(Reactive Oxygen Species).
Under oxidative stress on neurons,
carnosine and anserine regulate cell
stability and participate in the (Boldyrev,
selection of preferred pathway for 2000)
neuronal cell death (necrosis or
apoptosis).
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et

6.

Behavioral attributes

Protects against amydaloid kindled (Jin et
seizures in rats.
2005)

al.,

7.

Potential treatment for AGE (Advance Glycation End (Reddy et al.,
Alzheimer’s Disease (AD) Products) and RAGE (Receptors for 2005)
Advance Glycation End products)
accumulate in amyloid plaques in
AD. Carnosine attenuates the
formation of AGE and thus can be a
potential treatment for AD.

8.

Anti-ageing properties

Carnosine acts as a potential anti- (Gallant et al.,
senescence drug, improves external 2000)
appearance,
and
physiological
functions in experimental mice.
Carnosine reacts with protein
carbonyls to form protein carbonyl (Hipkiss and
carnosine
adducts
called Brownson,
“carnosinylated”
proteins;
thus 2000)
produces
anti-ageing
and
rejuvenating effects.
Carnosine attenuates the formation of
age presumably by sequestering (Reddy et al.,
reactive 1, 2- dicarbonyl compounds. 2005;
Boldyrev et al.,
1999)

9.

Minimizing DNA Damage

Helps in minimizing DNA damage (Reddy et al.,
by sequestering ROS (reactive 2005)
oxygen species; H2O2, superoxide,
hydroxyl radicals, HOCl) and RNS
(reactive
nitrogen
species;
Peroxynitrite, HNE: trans-4-hyroxy2-nonenal).

10.

Immune system

Helps in building immunity.

(Knight, 2000)

Cofactor in defensive action of (Nagai, 1971)
cortisones.
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11.

Cardiovascular Effect

Carnosine acts as a modulator of (Roberts and
calcium regulated proteins in cardiac Zaloga, 2000)
muscle cells and thus important for
contractility and cardiac function.
Carnosine produces relaxation of
isolated rat aorta independent of
endothelium, this effect is partly (Ririe et al.,
mediated via cyclic GMP production 2000)
and is not produced by its constituent
amino acids, L-histidine and βalanine.

12.

Anti-ischemic activity

In brain and heart, anti-ischemic
effect of carnosine is due to
combination of antioxidant and
membrane protecting activity, proton
buffering capacity and formation of
complexes with transition metals. In
cerebral
ischemia,
carnosine
decreases mortality and is beneficial
in neurological conditions while in
cardiac ischemia, carnosine protects
cardiomyocytes from damage and
improves contractility.

(Stvolinsky
and Dobrota,
2000;
Alabovsky et
al., 1997)

13.

Enzyme regulation

Regulates muscle phosphorylases

(Johnson and
Aldstadt, 1984)

14.

Calcium regulation

Carnosine acts as endogenous (Batrukova and
regulator of sarcoplasmic reticulum Rubtsov, 1997)
Ca release channel in skeletal
muscles.
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2.7.

Synthetic Carnosine versus Natural Carnosine
Carnosine can be chemically synthesized or extracted from skeletal muscles as a

natural source by various extraction methods. Methods of chemical synthesis of carnosine
and disadvantages of synthetic carnosine are discussed in this section.

Methods of Chemical Synthesis of Carnosine
A simple and efficient method of chemical synthesis of carnosine was suggested by
Vinick and Stanley (1983). They used a coupling reaction between NTA N-(thiocarboxy)
anhydride of β-alanine with L-histidine under controlled pH (8.1 to 9.4) and exploited the
isoelectric point (8.2) of carnosine to obtain a 79% carnosine recovery. Carnosine can
also be prepared synthetically using phthaloyl (Turner, 1953). In this method, phthaloylβ-alanine chloride and L-histidine are condensed at lower temperatures in the presence of
trimethylamine resulting in the formation of phthaloyl-β-alanylhistidine and later
carnosine was isolated by detachment of phthaloyl group using hydrazine.

Disadvantages of Synthetic Carnosine
Synthetic preparation of pure carnosine contains hydrazines in the range of 0.01 to
0.20% (w/w) (Decker et al., 2000; Zhou et al., 1998). These levels are capable of
interfering in analyzing antioxidant properties of carnosine since hydrazine also possesses
antioxidant properties. Hydrazines are powerful reducing agents which can inactivate free
radicals and accelerate metal promoted decomposition of lipid peroxides (Schmidt,
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2001). Therefore, presence of hydrazines might lead to flawed interpretation when
evaluating antioxidant properties of synthetic derivatives of carnosine.
Some Japanese pharmaceutical companies have preferred natural carnosine over
synthetic carnosine for use in clinical trials due to the relatively low manufacturing cost
and lower level chemical contaminants (hydrazines) (Quinn et al., 1992). Therefore, there
is a desire for extraction of carnosine in the native form with minimal or no use of
chemicals.

2.8.

Extraction of Carnosine
The first systematic extraction of carnosine from beef extract was conducted by

Guelwitsh in 1900 (Guelwitsch 1900; 1906; and 1911). Since then, carnosine has been
extracted from a wide variety of animals; including buffalo, cat, chicken, beef, chum,
crab, dolphin, dog, donkey, frog, Giant oyster, sheep, Siberian salmon, snake, sturgeon,
squid, swine, trout, turkey, wallaby and blue whale. Table 2.2 provides a summary of the
source and amounts of carnosine extracted from different animal muscles.
Carnosine and anserine extraction have been conducted from mammalian skeletal
muscle (cat, dog, deer, gnu, oppossum and llama) by Wolff and Wilson (1935).
Carnosine is present in as high as 20 mM in mammalian skeletal muscles and in lower
levels in the central nervous system (Guiotto et al., 2005). Carnosine can be extracted
from muscle tissues by simple hot water extraction or by use of acids such as
hydrochloric acid, perchloric acid. According to the study conducted by Winnick et al
(1963) using histidine

14

C and β-alanine
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C radioactive isotopes, during extraction

more than 95% of radioactive peptides were present in the supernatant centrifuged at
15,000 g and negligible amounts were present in the pellet, indicating that centrifugation
was an effective method for extraction of carnosine.
Carnegie et al (1983) used 0.9% saline and 8% sulfosalicyclic acid with
centrifugation at 10,000 g and filtration to extract carnosine from meat; while heating of
extract, centrifugation, and ultrafiltration technique were used on chicken extract
(Maikhunthod and Intarapichet, 2005) and mechanically separated pork extract
(Gopalakrishnan et al., 1999). Carnosine and total iron recovery increased with increased
heating temperature in broiler thigh and breast meat (Maikhunthod and Intarapichet,
2005) while Gopalkrishnan et al. (1999) found that protein and iron content decreased
with increases in temperature (60, 70, 80°C) in deboned pork extract. Maikhunthod and
Intarapichet (2005) reported carnosine levels about 7 times higher in chicken breast
(2900.1 μg/gm) than thigh (419.9 μg/gm) muscle. These researchers extracted carnosine
at 60, 80, 100°C and with ultrafiltration (500 MW cut off). They also found that the 80°C
ultrafiltrate had 20% higher carnosine but 40% lower protein levels and 10-30% lower
iron concentrations than the 60°C heated ultrafiltrate; thus an increase in extraction
temperature increased carnosine content while decreasing the mineral content.
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Table 2.2: Source and amount of carnosine extracted/recovered from various
muscle foods.
Muscle Type

Source

Amount

Reference

Beef

M.
Semimembranosus

379mg/100gm of muscle

(Chan
1993)

Top side rump

333 mg/100gm tissue

Shin

(Carnegie et al.,
1983)

396mg/100gm tissue

Femoris

158mg/100gm

Myocardium

23mg/100gm

(Boldyrev,
1987)

Breast

290mg/100gm

(Maikhunthod
and
Intarapichet,
2005)

Breast

400mg/100gm

(Plowman et al.,
1988)

Breast

271mg/100gm
extract

Thigh

42mg/100gm

Leg

124mg/100gm

Chicken

Swine

Crab

Pectoralis

271mg/100gm

Longissimus dorsi

240mg/100gm

Shoulder and legs

276mg/100gm

Loin and shoulder

466mg/100gm

Deboned extract

105mg/100gm

0

0

et

al.,

(Boldyrev et al.,
1988)

of

liquid (Quinn et al.,
1992)
(Maikhunthod
and
Intarapichet,
2005)
(Plowman et al.,
1988)
(Boldyrev,
1987)
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(Easter
and
Baker, 1977)
(Carnegie et al.,
1983)
(Gopalakrishnan
et al., 1999)
(Boldyrev

and

Severin, 1990)
Giant Oyster

0

0

(Boldyrev and
Severin, 1990)

Sheep

Shoulder and leg

111mg/100gm

Shoulder and leg

173mg/100gm

(Carnegie et al.,
1983)

Leg

190mg/100gm

Siberian
Salmon

NI

0

(Boldyrev and
Severin, 1990)

Turkey

Pectoral

538mg/100gm

Leg

239mg/100gm

(Wołos et al.,
1982)

Leg

260 mg/100gm

Breast

240mg/100gm

(Davies et al.,
1978)

The contents of the table were adapted from the review article by Chan and Decker
(1994) and also additional carnosine values and references were added. Units are changed
to mg/100gm (as the values indicated by the authors) for the uniformity of the table.

2.9.

Antioxidant Activity of Carnosine
Oxidation of lipids occurs in three steps which are initiation, propagation and

termination (Fenemma, 1996).
Step 1: Initiation can involve catalysts such as Fe2+, Mn

2+

, Co2+, sunlight, another free

radical or high energy sources to start the reaction that abstracts hydrogen from RH to
form R.
RH + X.
RH + M III

R. + XH
R. + H+ +M II

(Metal ion)
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Step 2: In propagation free radicals react to create peroxides and other free radicals
R. + O2

ROO.

ROO. +RH

ROOH+R.

Step 3: Termination, formation of stable end products.
R. +R.
R. +ROO.

Nonradical products

ROO. +ROO.

Antioxidants are defined as the substances that can delay onset or slow the rate of
oxidation (Fenemma, 1996). They can act by inhibiting the chain reaction.
ROO. + AH

ROOH + A.

Antioxidants can be generally classified into four types based on the mechanism of action
(Dziezak, 1986); (1) free radical scavenger, (2) peroxide decomposer, (3) metal chelator
and (4) reactive oxygen scavenger. Other antioxidant-related effects include singlet
oxygen quenching as with β-carotene, prevention of iron (Fe) cell membrane binding by
zinc, activation of glutathione peroxidase activity by selenium and degradation of highly
reactive hydrogen peroxide as with catalase.
Several researchers have reported various modes of antioxidant activity for
carnosine. It acts as metal chelator, reactive oxygen scavenger, free radical scavenger and
peroxide decomposer (Chan et al., 1993; Chan and Decker., 1994; Reddy et al., 2005;
Baran, 2000). Carnosine protects against oxidation due to its reducing capacity (which is

20

related to breaking of radical chain by donation of a hydrogen atom), reactive hydroxyl
radical scavenging and chelation of metal ions (Yen et al., 2002).
Various structure-function relationships of carnosine have also been published
(Kohen et al., 1988; Chan and Decker., 1994; Baran, 2000) which indicates the imidazole
ring of carnosine and the peptide linkage between histidine and β-alanine are responsible
for its antioxidant capacity (Wu et al., 2003).

Figure 2.3: Carnosine Structure

Imidazole ring

Imidazole alone had 39% inhibition against peroxyl radicals and suggested that
hydrogen on the methylene carbon next to imidazole ring is likely to be a proton donor
which retards oxidation (Kohen et al., 1988). Chan and Decker (1994) supported the
theory that the antioxidant properties of carnosine could also be attributed to the peptide
bond present between β-alanine and histidine and not by histidine and β-alanine alone
(Chan and Decker, 1994); similar results were found by Wu et al (2003).

2.10.

Metal Chelating Activity of Carnosine

Carnosine acts as a metal chelator and prevents metal catalysts from initiating
oxidation reactions. Carnosine forms a complex with copper, zinc, vanadium, nickel and
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manganese ions (Baran, 2000). The protonated nitrogen (N3) in the imidazole ring
interacts with copper (Cu2+) and zinc (Zn2+) ions and thus makes a stable metal complex
(Chan and Decker., 1994; Decker et al., 1992; Baran, 2000). Carnosine and anserine are
excellent Cu2+ chelating agents. Carnosine has the ability to inhibit the oxidation of
deoxyguanosine induced by ascorbic acid plus copper ions due to chelation of copper
(Kohen et al., 1988).

2.11.

Oxygen Radical Scavenging Capacity of Carnosine

The antioxidant activity of carnosine, homocarnosine and anserine against peroxyl
radicals has been studied by Kohen et al. (1988) using voltametric measurements in
AMVN {2,2-azobis (2,4-dimethylvaleronitrile)} and AAPH { 2,2’-azobis(2-amidinopropane dihydrochloride) }systems under physiological conditions. They also compared
different structures such as carnosine, anserine, GABA {γ-amino butyric acid}, Lalanine, β-alanine and found that carnosine has 53% inhibition against peroxyl radicals
while anserine showed 39% and GABA, L-alanine, β-alanine showed no inhibition.
Histidine displayed 42% while histamine showed 28% inhibition against peroxyl radicals
due to donation of hydrogen atom to the peroxyl radicals.
Carnosine is composed of β-alanine and L-histidine, and based on previous research
studies histidine possesses stronger antioxidant properties. For instance, Chan and his
colleagues in 1992 reported that histidine and histidine containing dipeptides were able to
quench 49.1 to 94.9 % of hydroxyl radicals produced by Fe2+ and H2O2 (Chan et al.,
1992). They used electron magnetic resonance spin trapping to determine that carnosine
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was the most efficient inhibitor of hydroxyl radicals in phosphatidyl choline liposome
emulsion followed by homocarnosine > histidine >gly-histidine >glycine-GABA > βalanine (Chan et al., 1992).
During the study of carnosine inhibitory effect on the oxidation of lipids, proteins,
deoxyribose oxidation and liposomes, Yen et al (2002) reported that carnosine stabilizes
proteins against oxidation. Carnosine also inhibits the formation of protein carbonylation
products which occurs due to oxidative stress on proteins (Aldini et al., 2005). Boldyrev
et al (1990) and Yen et al (2002) studied the effect of carnosine, anserine, histidine and
homocarnosine on luminol and lucigenin-dependent chemiluminescence of rabbit
leukocytes which were activated by BaSO4. These researchers found that anserine was
most effective inhibitor followed by carnosine.
H2O2 +
Hydrogen Peroxide

Cl2.
Chloride

OCl.

+

Hypochlorus anions

H2O
water

Carnosine caused suppression of hypochlorus anions and formed stable chloramine
complexes and in addition had an inhibitory effect on the myeloperoxidase enzyme itself.

2.12.

Factors Affecting Antioxidant Capacity of Carnosine

Antioxidant capacity of carnosine could be affected by pH and temperature and the
effect of these factors are discussed in detail in the following section.
2.12.1. Effect of pH on antioxidant activity
pH has a significant effect on the antioxidant activity of carnosine. A decrease in
pH can cause a decrease in antioxidant activity however since carnosine acts as a buffer,
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pH is maintained around the physiological range enabling carnosine to reduce oxidative
stress in animal tissue (Kohen et al., 1988).
In 1990, Decker and Faraji found that the antioxidant activity of carnosine was
unaffected over the pH range of 5.1-7.1 in meat and in aqueous solution while Boldrev
and Severin (1990) found that the ability of carnosine to extend the lag phase of oxidation
was decreased when pH was increased from 6.0. The relation between carnosine
inhibition of lipid peroxidation and pH was also examined by Lee and Hendricks (1997).
They found that at pH 6.0 the presence of carnosine reduced TBARS formation by two to
three times greater than at pH 7.0. At the same pH, TBARS formation decreased as the
concentration of carnosine increased from 0.02 mM to 20 mM.

2.12.2. Effect of heat on antioxidant activity
Heating carnosine at 100°C for 15 min had no effect on its ability to inhibit
lipid oxidation (Decker and Faraji., 1990). Chan et al (1993) extracted carnosine from
beef muscle using three treatments, unheated, 60°C and 100°C; and found that
antioxidant activity of unheated muscle extract was not different from that of 60°C
treatment while 100°C heating increased its antioxidant activity by 8.6 times. Increased
antioxidant activity after heating at 100°C was due to removal of total iron (98%
removed) from the extracts which act as pro-oxidants. They also found that antioxidant
activity of the beef extract was affected little by freeze drying but was increased by
vacuum drying. Carnosine extracted from chicken breast and thigh at 80°C had greater
antioxidant activity than carnosine extracted at 60°C (Maikhunthod and Intarapichet,
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2005). Similar results were found by Gopalakrishnan et al., (1999) in deboned pork
extract exposed to (60, 70, 80°C) various temperatures. They suggested that with the
increase in temperature, carnosine recovery was increased while iron recovery decreased
which improved the net overall antioxidant activity of the extract due to less prooxidative compounds and greater carnosine extraction. Removal of pro-oxidants such as
iron in order to increase the antioxidant activity was suggested by various scientists
(Gopalakrishnan et al., 1999; Chan et al., 1993; Maikhunthod and Intarapichet, 2005).

2.13.

Applications in Food

Carnosine may have applications as a natural antioxidant in foods, thus retarding lipid
oxidation and retaining meat color during storage. Various scientists have explored the
possible application of carnosine in food.
Decker et al (1991) found that carnosine is capable of preserving the red color of pork
meat, thus can be used to improve retention of quality in fresh cut meat and also
suggested that color stabilization was due to carnosine’s antioxidant activity (Decker et
al., 1995). Carnosine can also preserve meat color by preventing the formation of
metmyoglobin (James et al., 1995).
Antioxidant activity of carnosine along with gamma irradiation of ground beef and
beef patties was studied by Badr (2007). It was observed that carnosine significantly
reduced oxidation and metmyoglobin formation in samples during storage. Badr (2007)
concluded that carnosine can be used as a natural antioxidant to increase the oxidative
stability of gamma irradiated raw and cooked meat products.
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Djenane et al (2004) studied the antioxidant effect of carnosine (50mM), carnitine
(50mM) and L-ascorbic acid solutions (500ppm) in fresh beef steaks stored under
modified atmosphere. The combination of carnosine with ascorbic acid provided the best
protection against oxidative deterioration when compared with carnosine, carnitine and
ascorbic acid alone. The surface application of carnosine to meat delayed oxidation of
meat more effectively than carnitine.
The effect of preblending of carnosine at levels 0, 0.5, 1 and 1.5% on the quality of
ground buffalo meat under refrigeration (4 ± 1°C) was measured by Das et al (2006).
Samples containing 1% and 1.5% carnosine significantly inhibited metmyoglobin
formation and brown color development. Carnosine also increased water holding
capacity, meat pH, cooking yield and oxidative stability when compared to control
samples. These researchers concluded that 1% preblended carnosine with ground buffalo
meat extended its shelf life by 8 days under refrigerated storage (Das et al, 2006).
Decker et al (1991) reported carnosine (0.5 and 1.5%) effectively inhibited formation
of lipid peroxides and TBARS in frozen (− 15°C) salted ground pork for up to 6 months
of storage. Carnosine (1.5%) was compared with sodium tri-polyphosphate (0.5%), αtocopherol and butylated hydroxytoluene (0.02% of fat content) and found that inhibition
of TBARS formation by carnosine was better than the other compounds tested. Moreover
carnosine was the most effective in preventing oxidative rancidity and color changes as
determined by sensory panel, in salted ground pork after 1 month of frozen storage
(−15°C). In a similar study, Decker and Crum (1993) found antioxidant activity of
carnosine in cooked salted and unsalted ground pork was greater than that of lipid-soluble
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free radical scavengers, butylated hydroxytoluene and α-tocopherol but less than that of
sodium tripolyphosphate. They concluded that carnosine could be used to reduce the
oxidative deterioration of cooked salted and unsalted ground pork.
O Neill et al (1998) studied lipid oxidation in raw and cooked chicken thigh patties
obtained from chicken fed with supplementary dietary α-tocopherols. They added
carnosine (0-1.5%) into the patties and found that 1.5% carnosine provided the best
antioxidant capacity in both raw and cooked patties up to 10 days and 7 days
respectively, under refrigerated storage. These researchers also found that carnosine had a
similar antioxidant effect as a dietary α-tocopherol supplement under refrigerated
conditions and that α-tocopherols and carnosine acted synergistically having greater
antioxidant activity together than when used singly. These same researchers (O'Neill et
al., 1999) also found that carnosine (1.5%) inhibited both lipid oxidation as well as
cholesterol oxidation in salted chicken thigh patties. Dietary supplementation of
carnosine (0.5%) in live chicken increased breast and thigh muscle weight significantly
and also significantly decreased TBARS values and increased total antioxidant capacity
in meat.
Dietary supplementation of carnosine along with α-tocopherol was more effective in
decreasing TBARS formation in rat skeletal muscle homogenate than carnosine alone,
suggesting carnosine and α-tocopherol act synergistically preventing TBARS formation
in skeletal muscle homogenate (Chan et al., 1994). Carnosine antioxidant activity and its
effect on volatile compounds produced by lipid oxidation was studied in a meat model
system by Kansci et al (1997). They induced oxidation by using Fe III and ascorbate 45
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μM each. Carnosine (2-10 mM) showed a decrease in lipid oxidation, TBARS, c t-2undecenal, total 2-alkenals and hexanol levels.
Meat ageing had no effect on carnosine and anserine concentrations in ready to eat
beef meat while the concentration of these dipeptides decreased 82.6% and 76.0%,
respectively, of their initial values after cooking at 75°C for 90min (Bauchart et al.,
2006).

To summarize, carnosine was discovered from beef extract but a century after its
discovery, little published research has been conducted relating to carnosine’s possible
microbicidal or food safety potential. Although it is known for flavor, color and
antioxidant properties in foods, more work is needed to explore the use of carnosine as a
shelf life extender of food products.
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CHAPTER THREE
EXTRACTION OF CARNOSINE FROM DIFFERENT POULTRY BY-PRODUCTS
AND MEASURING ITS ANTIOXIDANT PROPERTIES

Abstract
The aim of the present research was (1) to extract carnosine from different poultry
by-products and (2) to measure their antioxidant activities using different analytical
methods. Poultry by-products such as head, liver, lungs, tail, gizzard, brain and heart
were collected from a poultry processing facility. Carnosine was extracted using a hot
water extraction and the content was analyzed using HPLC. Thiobarbituric Acid Reactive
Species (TBARS) inhibition, metal chelating activity, free radical scavenging activity and
Oxygen Radical Absorbing Capacity (ORAC) values were used as parameters to evaluate
antioxidant activity of the extract. Carnosine was present in all the tissue samples
investigated. Liver had the highest (102.29 mg/gm) and brain the lowest carnosine
content (0.95 mg/gm) (p ≤ 0.05). Except for the brain, all tissue ultrafiltrates and
reconstituted dry powders showed TBARS inhibition ranging from 20.87-39.57% and
5.66 -14.47%, respectively. Head ultrafiltrate and reconstituted dry powder had the
maximum while gizzard exhibited the minimum metal chelating activity (p ≤ 0.05). Free
radical scavenging activity of ultrafiltrate from all tissues samples ranged from 25.11 to
79.38%, while this activity was higher (29.76 to 84.05%) in the reconstituted dry powder
of all tissue samples. ORAC values were highest in liver ultrafiltrate and lowest in heart
(p ≤ 0.05), with a similar trend in reconstituted samples with liver the highest and head
the lowest ORAC values (p ≤ 0.05).
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Conclusions include that the carnosine was present in the poultry by-products
ultrafiltrates, as well as its dry powder and it possesses antioxidant properties.

Abbreviations: ORAC = Oxygen Radical Absorbing Capacity; TBARS= Thiobarbituric
Acid Reactive Species; TE= Trolox Equivalents
Keywords: Carnosine, antioxidants, TBARS, metal chelating, free radical scavenging,
ORAC, poultry by-products
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3.1. Introduction
More than a century ago in 1900, carnosine was extracted from Leibig’s extract
(beef extract) by Guelwitsh (Guelwitsch and Amiradgibi, 1900; Guelwitsch, 1906;
Guelwitsch, 1911). Later, upon systematic analysis, it was determined that this water
soluble dipeptide is composed of β-alanine and L-histidine and acts as a buffer in the
muscle (Davey, 1960; Skulachev, 2000; Smith, 1938), a potent antioxidant in skeletal
muscles (Chan and Decker., 1994; Kohen et al., 1988), a neurotransmitter in the brain
(Trombley et al., 2000; Tomonaga et al., 2004; Tomonaga et al., 2005) and an aid in
muscle contraction in skeletal tissues (Avena and Bowen, 1969; Severin et al.,1963).
Carnosine also regulates calcium proteins in cardiac muscles (Roberts and Zaloga, 2000),
exhibits anti-ageing effects (Hipkiss, 1998; Hipkiss and Brownson, 2000; Reddy et al.,
2005) and chelates metal ions (Baran, 2000; Chan and Decker., 1994; Kohen et al.,
1988). Carnosine has been proposed as a cure for Alziehmer’s disease (Reddy et al.,
2005), senile cataracts (Babizhayev et al., 2009), Wilsons disease (by chelation of Cu
ions), gastric ulcers due to membrane protection activity (Matsukura and Tanaka, 2000),
wounds and inflammation (Boldyrev and Severin, 1990; Nagai, 1980). In addition, oral
intake of carnosine has been found to improve high intensity and exercise performance
and endurance in humans (Sato et al., 2003). To summarize, since its discovery, extensive
research has shown that carnosine is a potential therapeutic food and/ or dietary
supplement.
Food scientists have interest in carnosine due to its antioxidant properties.
Antioxidants are substances that retard rates of oxidation reactions when added to food
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products. Antioxidants in food can be categorized as natural antioxidants (such as
Vitamin E and ascorbic acid) and synthetic antioxidants [such as butylated hydroxy
anisole (BHA), butylated hydroxy toluene (BHT), propyl gallate (PG) and tert-butyl
hydroquinone (TBHQ)]. Synthetic antioxidants (BHA, BHT etc.) are strictly regulated by
the FDA (Food and Drug Administration) due to lingering concerns about toxicity at
elevated levels (Branen, 1975; Ito et al., 1986). Therefore, research has been conducted
to identify natural antioxidants from different sources to minimize the need for synthetic
antioxidants and to enhance the nutritional quality of food. Several researchers have
reported that carnosine inhibits autooxidation in lipids and cell membranes by chelating
metal ions, scavenging reactive oxygen, scavenging free radicals and by decomposing
peroxides (Baran, 2000; Chan and Decker, 1994; Reddy et al., 2005; Decker and Faraji,
1990). Preventing oxidation of food products increases shelf life and maintains food
quality for longer period of time. Oxidation of lipids in foods can lead to loss of sensory
and nutritional quality and may also result in formation of toxic compounds posing health
concerns such as atherosclerosis, cytotoxicity, mutagenesis and carcinogenesis (Gray et
al., 1996). There is interest in carnosine as a natural antioxidant in the food industry,
especially since there are no toxic effects associated with consumption of carnosine or its
derivatives (Quinn et al., 1992; Sato et al., 2008) and excess carnosine is excreted through
urine (Perry et al., 1967).
Since its isolation from beef extract, carnosine has been extracted from a variety
of other animal tissues including mammalian skeletal muscle tissues of cat, dog, deer,
gnu, oppossum, llama (Wolff and Wilson, 1935) and turkey (Davis et al., 1978).
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Carnosine was found as high as 20 mM levels in mammalian skeletal muscles but in
relatively lower levels in the central nervous system (Guiotto et al., 2005). Carnosine has
also been extracted from mechanically deboned pork (Gopalakrishnan et al., 1999),
poultry breast meat (Maikhunthod and Intarapichet, 2005) and from isolated muscle
protein waste material (James et al., 1995).
According to a recent report in 2009, approximately 8.7 billion chickens were
slaughtered in the United States resulting in production of 1.16 million metric tons of
poultry by-product meal, 0.6 million metric tons of poultry fat and 0.5 million metric tons
of feather meal (Swisher, 2009). At present, most of poultry by-products are being
utilized by the rendering industry to produce protein meal and fat.
Little published information is available on extraction of antioxidants such as
carnosine from poultry by-products. Therefore, the objective of the present research was
(1) to isolate carnosine from different poultry by-products and (2) to determine its
antioxidant properties using different analytical methods.

3.2.

Materials and Methods

3. 2.1. Reagents
Trolox- [(±)- 6-hydroxy-2, 5, 7, 8- tetramethyl-chroman-2-carboxylic acid; CAS#
53118-07-1], ferrous chloride [CAS# 7758-94-3], ferrozine [3-(2-pyridyl)-5,6-diphenyl1,2,4-triazine-4’,4”-disulfonic acid sodium salt; CAS#69898-45-9], TCA [ trichloroacetic
acid; CAS# 76-03-9], DPPH [2,2-diphenyl-1-picryl-hydrazyl; CAS# 1898-66-4],
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fluorescein sodium salt [CAS# 518-47-8], 2-thiobarbituric acid [CAS# 504-17-6], Lcarnosine [CAS # 305-84-0], BSA [bovine serum albumin; CAS# 9048-46-8], OPA
[phthaldialdehyde reagent; Product # 057K5015], L-α-phosphatidylcholine Type IV-S
[CAS# 8002-43-5], AAPH [ 2,2’- azobis (2-methylpropion-amidine) dihydrochloride
97% ; CAS # 2997-92-4] and TEP [3,3,3-tetarethoxypropane; CAS# 122-31-6] were
purchased from Sigma Aldrich chemical company(St. Louis, Missouri, USA). Sodium
acetate trihydrate [CAS# 6131-90-4], methanol- HPLC grade (0.2µm filtered) [CAS #
67-56-1], acetonitrile- HPLC grade (0.2µm filtered) [CAS # 75-05-8] were purchased
from Fisher Scientific (Fair-lawn, New Jersey, USA). L-ascorbic acid sodium [ CAS #
134-03-2] and 4-bromoaniline [CAS# 106-40-1] were purchased from Arcos Organics
(New Jersey, USA) while BHT [butylated hydroxytoluene] CAS# 128-37-0 was
purchased from MP Biomedical, Inc (Solon , Ohio, USA). All reagents were ACS grades
or purer.

3.2.2. Sample Procurement and Preparation
Tissues samples from freshly slaughtered commercial broilers (approximately 6
weeks of age) were procured from a local poultry processing facility. Samples were
packed in ice then transported to the laboratory. Upon arrival to the laboratory head and
gizzard samples were prepared on the same day and packed in plastic bags and stored at 80°C± 2°C until further analysis. The other tissue samples were stored at -20°C± 2°C and
prepared next day, packed in the plastic bags and stored at -80°C± 2°C until further
analysis.
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3.2.2.1. Preparation of Sample
Gizzard: Excess fat from the gizzard was removed. The gizzards were then cut
open to remove any material followed by peeling off the inside thick lining. After
peeling the thick lining (cutica gastrica), the gizzards were washed under lukewarm tap
water to remove any additional adhering material, washed gizzards were dried using
paper towel.
Head: The beak, comb, and skin were removed form each head using shears.
Brain: Brain samples were prepared from head by cutting open the skull using
surgical scissors. Exposed brain tissues were removed using a spatula.
Tail: The skin, oil gland and adhering fat were removed to prepare the tails for
grinding.
Liver: Liver was trimmed to remove excess fat layer and gall bladder if attached.
Heart: Fat and the epithelial membrane were removed from each heart.
Lungs: Any attached fat and bronchial tubes were removed from lungs.
All prepared tissues were ground using an America Eagle Meat Grinder (Model #
AE-G12, Serial # 12SS912029, American Eagle Food Machinery Inc., Chicago, IL,
USA). The ground tissue samples were packed in plastic bags and stored at -80±2°C until
further analysis.
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3.2.3. Extraction of Carnosine
Carnosine was extracted the method as described by Maikhunthod and
Intarapichet (2005) with slight modifications (Figure 3.1). To one part of minced sample,
two parts of pre-cooled (4°C) nano pure water was added and samples were homogenized
in a blender (Ostersizer Model # 4937, Sunbeam Products Inc., Boca Raton, Florida,
USA) using 4 cylcles of 2min each cycle with 2 min cooling with ice slush between each
cycle (8 min total homogenization). The homogenate was centrifuged at 20,000 g for 30
min at 4°C in Sorval RC-5B refrigerated super speed centrifuge (Du-Pont Instruments,
Wilimgton, DE, USA). The supernatant was then filtered through Whatman #4 filter
paper (GE Healthcare Bio-Sciences Corp., Piscataway, New Jersey, USA). The water
extracted filtrate (supernatant) was subjected to a heat treatment at 80°C for 15 min in a
temperature controlled water bath (Precision, Model#283, Thermo scientific, Winchester,
VA, USA), followed by immediate cooling in an ice bath. The heated extract was
centrifuged at 6000 g for 20 min to remove precipitated proteins. Supernatant was filtered
through Whatman #4 filter paper.
The collected supernatant was then ultrafiltered using an Amicon Ultra-15 Filter
device (Catalog# UFC900324, Millipore, Billerica, MA, USA) with a 3000 molecular
weight cut off, using a centrifugal force of 4000g for 55 min at 14°C in a Beckman
Model J-6B centrifuge (Beckman Coulter Inc., Brea, CA, USA). Ultrafiltration permeate
was collected and divided into two portions; one portion of ultrafiltrate was stored at 80°C in plastic tubes until further analysis, while the second portion was freeze dried for
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72 hr using a Virtis freeze dryer (Model # 6201-3220,Virtis Company Inc., Gardiner,
NY, USA ) and stored as a dried powder at -80 °C until further analysis.
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Tissue Sample

Homogenize

First Centrifuge at 20000 g for 30 min at 4°C

Filter

Heat treatment 80°C for 15 min (Supernatent)

Second centrifuge at 6000 g for 20 min at 4°C

Filter

Extract (supernatant)

Ultra-filtration 3000MWCO (Centrifuge at 4000 g for 55 min at 14°C)

Ultra filtrate

Ultrafiltrate

Freeze drying

Freeze Dried Powder

Figure 3.1: Flow Chart of Extraction Procedure
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3.2.4. Determination of carnosine by Spectrophotometry
Spectrophotometric determination of carnosine was performed according to the
method described by Parker, (1980). One ml of sample to be analyzed was placed in a
glass tube and 1 ml of 0.04M EDTA, 1 ml of 20% Na2CO3 and 2 ml of diazotized pbromoaniline were added. This mixture was vortexed for 10 seconds with Vortex Genie
2

TM

(Model# G-560, Fisher Scientific, Bohemia, NY, USA). After 5 min, the reaction

was stopped by adding 95% ethanol afterwhich absorbance was measured at 500nm using
a spectrophotometer (Genesys 20, Model #4001/4; Themofisher Scientific, NJ, USA). A
standard curve was prepared using 20 to 100 μM pure carnosine plus above reagents. All
reagents were prepared freshly before each use.

3.2.5. Determination of carnosine by HPLC
High pressure liquid chromatography (HPLC) measurement of carnosine
concentration was conducted as described by Gopalakrishnan et al., (1999) and
Maikhunthod et al. (2005) with slight modifications.
To 2 ml of liquid ultrafiltrate or freeze-dried extract (25 mg/ml, reconstituted in nano
pure water), 2 ml of 0.4 M perchloric acid was added. The mixture was vortexed for 10
seconds (Vortex Genie 2

TM,

Model# G-560, Fisher Scientific, Bohemia, NY, USA),

boiled for 10 min (to precipitate proteins) and then centrifuged at 5000 g for 5 min at
4°C in Sorval

RC-5B refrigerated super speed centrifuge (Du-Pont Instruments,

Wilimgton, DE, USA) . After centrifugation, the supernatant was filtered through 0.45
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µm membrane filter. Filtrate was derivatized using phthaldialdehyde reagent (OPA) by
adding 100 µl of OPA to 500 µl of sample, just prior to injection onto a HPLC (Shimadzu
Instruments, Columbia, MD, USA).
OPA derivatized carnosine was separated using a mobile phase of 0.3 M sodium
acetate (pH 5.5), methanol and acetonitrile (75:15:10) @ flow rate of 0.75 ml/min using
Waters Spherisorb SCX-4.6 x 250 mm column (Waters Corporation, Milford, MA,
USA). Derivatized carnosine was detected using a fluorescence detector (RF551
Spectroflurometric detector, Shimadzu Instruments) with excitation wavelength of 310
nm and emission wavelength of 375 nm. The standard curve was prepared using a
standard carnosine solution (5 to 80 mM). The retention time and peak areas were
analyzed by EZ start 7.4 Software provided with the equipment (Shimadzu Instruments,
Columbia, MD, USA).

3.2.6. Antioxidant Activity Analysis
A multi antioxidant analytical approach was employed to better understand the
antioxidant mechanisms and to evaluate overall antioxidant capacity (Di Bernardini et al.,
2011; Zulueta et al., 2009; Frankel and Meyer, 2000).

In the current study, the

antioxidant activity of tissue sample (ultrafiltrate as well as reconstituted dry powder)
was measured by thiobarbituric acid reactive species (TBARS) inhibition, oxygen radical
absorbing capacity (ORAC), metal chelating activity and DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay as described below.
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3.2.6.1 Thiobarbituric acid reactive species (TBARS) Inhibition
TBARS measures malondiadehyde (MDA), the most abundant product of lipid
oxidation and other secondary products of the reaction. TBARS inhibition was tested
using a phosphatidyl choline emulsion system as described by Kansci et al (1997) and
Gopalkrishnan et al. (1999). The TBA/TCA reagent was prepared by the method
described by Tarladgis et al. (1960).
A 2 mg/ml phosphatidyl choline emulsion was prepared in 5 mM phosphate
buffer at pH 7.0 using a Polytron® PT2100 homogenizer (Capitol Scientific Inc., Austin,
Texas, USA). The phosphatidyl choline emulsion (1.8 ml) was mixed in 0.5 ml of sample
and held at room temperature for 5 min for interaction of sample with the emulsion. After
5 min, emulsion oxidation was initiated using catalysts FeCl2 (50 µl) and sodium
ascorbate (100 µl) to the final concentration of FeCl2 and sodium ascorbate of 40 µM
each in emulsion system.
The polypropylene tubes (BD Falcon, Mississauga, ON, Canada) containing the
mixture were incubated at 37°C in a temperature controlled water bath (Precison,
Model#283, Thermo scientific, Winchester, VA, USA) and after 2 hours, the reaction
was terminated by adding 50 µl of 10% BHT solution.

To each tube, 2.5 ml of

TBA/TCA solution was added and vortexed using a Vortex Genie 2

TM

(Model# G-560,

Fisher Scientific, Bohemia, New York) followed by heating in water bath at 90°C for 15
min. After heat treatment the tubes were cooled under running tap water and then
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centrifuged at 5000 g for 15 min at 4°C in Sorval RC-5B refrigerated super speed
centrifuge (Du-Pont Instruments, Wilimgton, DE, USA).
Absorbance was read at 531 nm using a spectrophotometer (Genesys 20, Model
#4001/4; Themofisher Scientific, NJ, USA) and water was used as a blank. MDA
(Malonaldehyde) was calculated using a standard curve prepared from TEP (1,1,3,3,tetraethpxypropane) at concentrations from 0 to 70 nM MDA. All reagents were freshly
prepared prior to experimentation. Emulsions without extract was used as a negative
controls.
Percent TBARS Inhibition was calculated using following formula:{(MDA without extract-MDA with extract) / MDA without extract} x100

3.2.6.2. Free radical scavenging assay
Free radical scavenging assay was performed as described by Yen et al. (2002).
DPPH radical (0.2mM) was dissolved in absolute ethanol.

2ml of ultrafiltrate or

reconstituted dry powder samples were mixed with 2ml of DPPH. The mixture was
allowed to stand for 30 min in dark and the absorbance of the resultant solution was
measured at 517nm with a spectrophotometer (Genesys 20, Model #4001/4; Themofisher
Scientific, NJ, USA). Mixtures without extract were taken as negative controls and
absolute ethanol was used as a blank.
Percent free radical scavenging was calculated as {(Absorbance of control at 517
nm – Absorbance of sample at 517 nm)/Absorbance of control at 517 nm} x 100
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3.2.6.3. Metal Chelating Activity
Chelating activity on ferrous ions (Fe 2+) was measured using the method described
by Yen and Wu (1999) with slight modifications. In this method, 1ml of ultrafiltrate or
reconstituted dried powder (25mg/ml) was mixed with 3.6 ml of distilled water and the
mixture was reacted with 200 µl of 2mM FeCl2 and 200 µl of 5mM ferrozine for 20 min
at ambient temperature. Absorbance was measured at 562nm using a spectrophotometer
(Genesys 20, Model #4001/4; Themofisher Scientific, NJ, USA). Nanopure water was
used as a blank. Tubes containing no extract were used as a negative control for
calculations and percent chelation was calculated using the following formula:{1- absorbance of the sample at 562 nm/ absorbance of control at 562 nm} x 100

3.2.6.4. Oxygen radical absorbing capacity assay
Oxygen radical absorbing capacity (ORAC) of the ultrafiltrate as well as of the
reconstituted dried powder (25mg/ml) was determined by hydrophilic ORAC method
described by Wu et al. (2008). The ultrafiltrate as well as reconstituted dried powder
(25mg/ml) were diluted 100 times with phosphate buffer (pH 7.4).
Twenty five microliter of the diluted sample or Trolox standard solution (0, 10,
20, 40, 60,100µM) or blank (phosphate buffer pH 7.4) was added to one of 96 well plates
(black with clear bottom, Optilux

TM

, BD Falcon). Flourescein solution (150µl) of 0.004

µM concentration was added to each well and the microplate was incubated at 37°C for
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30 min in VWR-Incubating mini shaker (Model#980150, VWR, Arlington Heights, IL,
USA). After 30 min incubation at 37°C, 25µl of AAPH solution (153mM) was added to
each well (as the peroxyl generator) using auto injector (BioTek Instruments, Inc.
Winnooski, Vermont, USA) to inititate the reaction. The microplate reader Synergy-HT
from BioTek Instruments, Inc (Winnooski, Vermont, USA) was programmed to measure
fluorescence at an excitation wavelength of 485 nm and an emission wavelength of
520nm at 1min time intervals for 1 hr and ORAC values were calculated using software
Gen5TM ( BioTek Instruments, Inc. Winnooski, Vermont, USA). The data were expressed
as Trolox equivalents (TE) per gram of original sample (dry basis).

3.2.7. Protein Content
Tissue samples were analyzed for protein content by the Agricultural Services
Laboratory at Clemson University using the Dumas method described in the Official
Methods of Analysis, section 968.06 (AOAC, 1990) using nitrogen/protein analyzer
(LECO Model# FP 528 ,Warrendale, PA, USA) .

3.2.8. Ash and Moisture Content
Moisture and ash content of the tissue samples was determined using official
methods of analysis, section 900.02A and section 950.46B respectively (AOAC, 1990).
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3.2.9. Total Mineral Content
Standard mineral contents in ultrafiltrate as well as reconstituted dried powder (25
mg/ml) were determined. Samples were diluted 1:10 for ultrafiltrate and 1:20 for
reconstituted dried powder (25 mg/ml) before determining the mineral content. The
samples were sent to Agricultural Services Laboratory at Clemson University where
mineral content was determined using inductively coupled plasma spectrometer
(SPECTRO ARCOS- ICP, Kleve, Germany).

3.2.10. Statistical Analysis
ANOVA was performed to determine overall differences in the group means. To
determine specific differences between pairs of group means, the Fisher LSD test was
used. Both tests used a Type I Error probability of 0.05 and the SAS (Statistical Analysis
Software Edition 9.2, SAS Institute Inc., 2007) was used to perform the statistical
calculations.

3.3. Results and Discussion
3.3.1. Time-temperature treatment for maximum recovery of carnosine
Maikhunthod and Intarapichet, (2005) reported a maximum recovery of carnosine
from broiler breast and thigh meat using 80°C for 10 min.

In our preliminary

experimentation, the centrifuged filtrate (Figure 3.1) was subjected to three different
58

temperature-time treatments in order to obtain maximum recovery of carnosine from
poultry by-products. These treatments were 80°C for 10 min., 80°C for 15 min., and 80°C
for 20 min in a temperature controlled water bath. The carnosine content was determined
using spectrophotometric methodology and there was no significant difference due to
these time-temperature treatments on the recovery of carnosine (p ≥ 0.05). Although not
statistically different (Figure 3.2), individual observations for recovery of carnosine at
80°C for 15min were slightly higher than other treatments (data not shown). Therefore,
80°C for 15 min treatment was used to get maximum recovery in future experimentation.

3.3.2. Mass Balance and Proximate Composition
Weights from the initial step (original sample) to final step (dry powder) of
carnosine extraction from by-products were recorded to calculate the mass balance of
extraction procedure (Table 3.1). Based on an initial weight of 100 gm (constant), we
found that liver provided the maximum yield of the powder while head provided lowest
yield. Liver contains iron, bile salts and enzymes while head sample contain skull bone
which plays a critical role during extraction or filtration step and thus affects the yield.
Also the lipid content in the head versus liver might be another possible cause for lower
recovery.
Among the group of tissues studied, dry solids were highest in tail tissue while lowest in
lungs (Table 3.2). Protein content was highest in liver while lowest in brain. The ash
content was highest in head and lowest in gizzard. The total mineral content of
reconstituted dried powder was much higher than that of ultrafiltrate (Table 3.7 and 3.8).
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3.3.3. Carnosine Content
Carnosine content determined by HPLC was highest (p≤0.05) in liver followed by
lungs (p ≤ 0.05); while the carnosine content of lungs was higher than heart, gizzard, tail,
head and brain tissues (p ≤ 0.05), and all these tissues did not differ (p ≥ 0.05) in
carnosine content (Table 3.2).
It was also observed that addition of OPA to prepared liver sample caused a
change in color. This may have been due to a reaction between liver components and
chemical reactants or due to the liver pH. A similar phenomena was observed in lung
extracts but to lesser extent, the exact cause of this color change was not determined.
Maikhunthod and Intarapichet (2005) reported carnosine levels of 2900.1 μg/gm
for chicken breast muscle and 419.9 μg/gm for thigh. These researchers extracted
carnosine at 60, 80, 100°C for 10min, and using ultrafiltration (500 MWCO). They also
found that 80°C ultrafiltrate had 20% higher carnosine but 40% lower protein levels and
10-30% lower iron concentrations than 60°C heated ultrafiltrate. All tissue samples in
the present study had higher carnosine content in breast and thigh than those reported by
Maikhunthod and Intarapichet (2005). This difference in carnosime recovery may be due
to the different temperature-time treatments (85°C/15min) used during extraction
procedure and due to discrepencies in detection methodology. Similar results were shown
in our preliminary experimentation.
Carnosine was present in all the tissue samples studied, which agreed with
previous researchers (Flancbaum et al., 1990) who measured carnosine in heart, kidney,
stomach, muscle, liver, spleen, lung, ileum, hypothalamus, pituitary and olfactory bulb of
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Hartley guinea pigs, mice and Spraguey-Dawley rats with the objective to determine
carnosine role in histidine metabolism. They suggested that carnosine could be a
reservoir for histidine-histamine metabolic pathway thus revealing another biochemical
role of carnosine in addition to its antioxidant properties.

3.3.4. Antioxidant Activity Analysis
3.3.4.1. TBARS Inhibition
Thiobarbituric acid reactive species (TBARS) inhibition by liver ultrafiltrate was
higher than that of other tissues (p ≤ 0.05), while head, lungs gizzard, heart and tail did
not differ (p ≥ 0.05) (Table 3.3). In reconstituted dry powder (25 mg/ml), gizzard
showed the highest antioxidant activity followed by liver, heart, head, lungs and tail
(Table 3.4). The inhibition values of tail and gizzard reconstituted dry powder differed
from that of other tissues (p ≤ 0.05).
No TBARS inhibition was exhibited by brain ultra-filtrate as well as its
reconstituted dry powder. TBARS inhibition of reconstituted dry powder of all tissue
samples was lower than their respective ultrafiltrates (Figure 3.3). This lower activity
may be due to higher mineral content in dry powder as compared to ultrafiltrate which
can increase oxidation rate. Relative to carnosine content present, TBARS inhibition of
head ultrafiltrate was 14 times greater than liver (Table 3.3). This indicates that there are
other compounds present in the liver interfering with TBARS inhibition or acting as
proxidants in the oxidation reaction. It is quite likely due to Fe present in liver which is
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about 48 times more than head ultrafiltrate (Table 3.7); this Fe could acts as a catalyst in
oxidation of phosphatidyl choline emulsion. It is also possible that there are other
antioxidant compounds (Kohen, 1998) found in the brain including antioxidant enzymes
as reported by Surai (1999).
Inhibition of TBARS by tissue ultrafiltrates as well as dry powder of the present
study was less than the values of broiler’s breast and thigh ultrafiltrate examined by
Maikhunthod et al., (2005). This may be due to sample differences and also due to
different concentrations of phosphatidyl choline emulsions used in the analyses as well as
different concentration of catalysts (FeCl2 and sodium ascorbate).

TBARS inhibition of

our tissue sample ultrafiltrates were higher while dry powder values were lower than the
TBARS inhibition obtained from mechanically deboned pork extract (Gopalakrishnan et
al., 1999).
Surai (1999) measured the activity of antioxidant enzymes superoxide dismutase,
glutathione oxidase, catalase in kidney, lung, liver, brain, heart, and skeletal muscles
(thigh) of chicken embryos and in one-day old chicks. All three enzymes exhibited
activity in the different organs studied, but the level of activity varied among the different
tissues. This study explained the ontogenic presence of antioxidant mechanisms during
development and post-hatching. This study also explained the possible presence of
antioxidant enzymes in the tissue sample of our study i.e. brain, liver, heart, lung and tail,
and these enzymes might contribute to some antioxidant activity in our analytical
methods.
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Kohen (1998) also reported that the brain contains other antioxidants such as
ascorbic acid (100 µM), urate (18 µM), homocarnosine (up to 50 µM), and anserine.
O'Dowd et al., (1990) also confirmed the presence of N-acetyl forms of histidine, 1methylhistidine, carnosine, anserine, and homocarnosine in rat brain using HPLC and
NMR (Nuclear magnetic resonance) spectroscopy.
Tail tissue is composed of skeletal muscle, bone, cartilage and an oil gland.
Skeletal muscles of chickens contain carnosine and anserine (Davis et al., 1978; Huang et
al., 2000; Maikhunthod and Intarapichet, 2005). Although the amount of skeletal muscle
in tail is much less than the breast and thigh this can contribute to carnosine content.
Besides carnosine, tail (skeletal muscle) might also contain anserine, glutathione and
polyamines such as spermine and spermidine which possess an activity similar to
carnosine (Zhou and Decker, 1999).
Lung lining fluid contains extracellular and cellular glutathione peroxidase
(Avissar et al., 1996) and in addition to these enzymes, skeletal muscles contain
carnosine, anerine, and superoxide dismutase (Chan and Decker., 1994). Other
hydrophilic antioxidants such as other small peptides like anserine, homocarnosine and
uric acid, ascorbates might be present in the tissue samples (Sacchetti et al., 2008) . These
water soluble molecules (amino acids and other small peptides) would be extracted with
carnosine in our extraction process. Thus, it is quite likely that these substances along
with carnosine (present in extract) contribute to the antioxidant activity of ultrafiltrate and
reconstituted dry powder.
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Furthermore, enzymes impart antioxidant activity similar to carnosine, such as
superoxide dismutase, catalase or glutathione oxidase and glutathione reductase
(Sacchetti et al., 2008; Chan and Decker, 1994). These enzymes can be partially
denatured or lose activity by the temperature treatment used which could contribute to
differences in activity. Carnosine is known to form complexes with certain divalent metal
ions such as Co, Cu, Mn, Zn, Cd, while K, Mg, Ca, Na do not bind with carnosine
(Boldyrev, 2007) The metal ions already present (Co, Cu, Mn, Zn, Cd) in the extract
might promote oxidation reaction or act as proxidants (when added into the emulsion
system of phosphatidyl choline) and thus, can lead to interference of the results.
As stated earlier, brain ultra-filtrate as well as reconstituted dry powder did not
show TBARS inhibition. This may be due to ascorbic acid found in brain tissue reducing
TBARS inhibition. According to Surai et al (1996), brain contained the greatest amount
of ascorbic acid compared to liver, heart, lung and kidney. Since we used ascorbate and
FeCl2 as a catalyst for phosphatidyl choline emulsion oxidation, the ascorbates already
present in the brain may act as proxidants synergistically with the catalysts used. The
same authors (Surai et al., 1996) also found that in vitro incubation of brain homogenate
with exogenous Fe2+ increased lipid peroxidation and thus, TBARS were much higher
than liver homogenate. These results were in agreement with the present study.
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3.3.4.2. Metal Chelating
Metal chelating activity of head ultrafiltrate was the highest followed by brain,
liver, tail, lungs, heart and gizzard. Metal chelating activity of all tissues were different (p
≤ 0.05) except brain and liver which were not different (p ≥ 0.05) (Table 3.3).
In reconstituted dry powder (25 mg/ml), head showed the highest metal chelation
followed by lungs, tail, heart, liver, brain and gizzard (Table 3.4). Metal chelating activity
of heart in comparison to lung and liver was not different (p ≥ 0.05) while other tissues
were different (p ≤ 0.05). Metal chelating activity of reconstituted dry powder of liver
and head was lower than its ultrafiltrate while in the rest of the tissue samples, the dried
powder showed more metal chelation than their ultrafiltrates (Figure 3.4).
Carnosine acts as a metal chelator and stops the oxidation reactions (Baran, 2000)
and it forms a ligand complex with Fe
2005).

2+

in similar manner as with Cu2+ (Huang et al.,

Relative to the carnosine content presence, head ultrafiltrate showed 22 times

more metal chelation than liver. This could be due to 20 times more iron already present
in the liver (3.6ppm) utrafiltrate than head (0.18ppm) (Table3.7). The presence of iron
could also promote color development during the assay by forming a complex with
ferrozine interfering with the assay results. Besides carnosine, there are other dipeptides
such as anserine which also plays a role in metal chelation and amino acids (such as
histidine) which form complexes with Fe2+ resulting in mixed ligand formation
(Boldyrev, 2007) changing metal chelation values. Huang (2000) also found that
demineralized breast extract gave higher metal (ferrous ion) chelation than unmineralized extract. Therefore, as suggested by other scientists, removal of proxidants
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such as iron helps increase the antioxidant activity of the ultrafiltrate (Chan et al., 1993;
Gopalakrishnan et al., 1999; Maikhunthod and Intarapichet, 2005).

So for better

evaluation of the metal chelation and TBARS inhibition, the demineralization of the
extract is a possible option however, this would add cost to process if commercialized.

3.3.4.3. Free Radical Scavenging
Ultrafiltrate of liver had the highest scavenging of DPPH radical followed by tail,
lungs, gizzard, brain, head and heart (Table 3.5). Except for tail and liver, the free radical
scavenging activity of all other tissue ultrafiltrates were significantly different (p ≤ 0.05).
Free radical scavenging of reconstituted dry powder was the highest in liver
followed by tail, heart, gizzard, lungs, head and brain (Figure 3.5). The values of tail and
heart as well as lungs and gizzard did not differ (p ≥ 0.05); all other values were
significantly different. Except brain, all tissue samples reconstituted dry powder exhibited
more free radical scavenging than their respective ultra-filtrates (Figure 3.5).
The inhibition of DPPH radical observed by Huang et al., (2000) in breast and
thigh extract was 71.0%. Some of our tissue samples (both ultrafiltrate and reconstituted
dry powder) showed higher values than those observed by these authors while some
tissue samples showed lesser values. When compared to the individual tissues samples
with respect to carnosine content presence, tail showed 18 times more free radical
scavenging activity than liver which implied that liver may contain other compounds
which interefere with the free radical scavenging ability of carnosine. In tail, other than
carnosine, aromatic amino acids (such as histidine, tyrosine, tryptophan) can donate
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protons or electrons to deficient radicals terminating the oxidation reaction. Cysteine,
non-aromatic amino acid, has direct interaction with radicals (Sarmadi and Ismail, 2010).
Polyamines also cause radical scavenging activity (Sacchetti et al., 2008) .

3.3.4.4. ORAC Values
ORAC assay is based on hydrogen atom donation by antioxidants to stabilize
peroxyl radicals produced by AAPH. In this method, the quantification is obtained from
kinetic curves derived from competitive kinetic reactions (Huang et al., 2005). ORAC
was highest in liver ultarfiltrate followed by gizzard, lungs, brain, head, tail and heart
(Table 3.5). ORAC values of heart, head and tail as well as lungs and gizzard did not
differ (p ≥ 0.05) while rest of the tissues were different (p ≤ 0.05).
In reconstituted dry powder, ORAC values were the highest in liver followed by
lungs and gizzard, heart, brain, tail and head. Except brain and heart, ORAC values of all
other tissues samples differed (p ≤ 0.05) (Table 3.6). Relative to carnosine presence,
ORAC values of gizzard were about 5 times more than liver, which implied that even
though liver is high in carnosine, the hydrogen donating ability of liver carnosine might
be interefered by other components. Overall, ORAC values of reconstituted dry powder
were less than their respective ultrafiltrates (Figure 3.6) which indicates that there is
overall loss in ORAC due to drying.
ORAC values of tissue samples studied were higher than hydrophilic extract of
beef samples obtained by Wu et al (2008).

Kohen et al (1988) determined antioxidant

activity of carnosine, homocarnosine and anserine against peroxyl radicals by using
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voltametric measurements in AMVN

{2,2-azobis (2,4-dimethylvaleronitrile)} and

AAPH { 2,2’-azobis(2-amidino-propane dihydrochloride) }systems under physiological
conditions. They found that carnosine has 53% inhibition against peroxyl radicals while
anserine showed 39% and GABA {γ-amino butyric acid}, L-alanine, β-alanine showed
no inhibition. Histidine displayed 42% while histamine showed 28% inhibition against
peroxyl radicals due to donation of hydrogen atom to the peroxyl radicals. Our samples
might contain other dipeptides such as anserine, homocarnosine which interact with
peroxyl radicals in the same way as carnosine thus affecting the ORAC antioxidant
capacity.
Overall, carnosine is present in the tissue investigated and all the tissues sample
ultrafiltrates as well as reconstituted dry powder showed TBARS inhibition except brain.
All the samples showed metal chelating, free radical scavenging and ORAC values. With
the freeze drying process, all the sample lose their antioxidant activity about 2 fold or
even more, so alternate method of drying such as vacuum drying could be explored.

3.4 Conclusions
The main objective of this study was to extract carnosine from the poultry byproducts, which could increase the revenue of the poultry processing or the rendering
industry. Carnosine was present in the poultry by-products ranging from 0.95 to 102.29
mg/gm sample (wb) and showed excellent antioxidant properties. Carnosine extraction
from poultry byproducts using hot water could be a cost-effective method and could
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produce excellent profit margins for manufacturers. There is an increasing demand of
producing novel functional foods containing bioactive peptides such as carnosine,
anserine and L-carnitine etc. (Arihara, 2006). Hence, extracted carnosine could be used
in formulated foods or in nutritional supplements for animals including pets with
increased therapeutic and nutritional values.
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TABLES AND FIGURES
Table 3.1: Mass balance of extraction process of carnosine from different organ samples (extract, ultrafiltrate
and freeze dried ultrafiltrate)

1.
2.
3.
4.

Organ

Sample wt.
(gm)

Supernatant
(gm)

Pellet
(gm)

Ultra filtrate
(gm) 3

Tail

100

135.57±5.18

146.67±3.52

Gizzard

100

174.29±6.84

120.50±14.46

Liver

100

190.67±2.37

90.56±3.60

Head

100

155.87±14.31

144.38±3.81

Brain

100

170.35±1.75

111.73±1.78

Lungs

100

205.67±9.85

78.94±6.22

Heart

100

197.31±4.84

81.21±3.04

116.60±2.56
(406.93)
166.33±0.97
(475.05)
184.27±3.15
(11946.22)
106.95±2.18
(337.37)
79.59±7.15
(349.81)
170.39±1.99
(1880.18)
180.49±2.67
(920.84)

Oversize
matter
(gm)
18.97±2.56
7.96±0.98
3.67±0.21
51.68±0.22
101.25±1.24
29.18±6.26
16.81±2.66

Freeze dried powder
(gm) Yield 4
0.96±0.21
(0.12)
1.26±0.16
(0.18)
3.88±0.32
(10.41)
0.57±0.08
(0.11)
0.61±0.07
(0.09)
1.18±0.38
(1.46)
1.34±0.02
(0.21)

Mean± SEM (N =3)
Two parts of nano pure water was added to each part of original sample weight.
Values in the ultrafiltrate column parenthesis indicate mg of carnosine present per 100 gm of original tissue sample.
Values in the freeze dried column parenthesis indicate mg of carnosine present per 100 gm of original sample.
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Table 3.2: Proximate composition: Organ Samples
Dry Solids
(%)

Moisture
Content (%)

Protein
Ash content Carnosine
content (%) (%)
content (wb)

Tail

42.60 ± 0.71

57.40± 0.71

17.10±1.89

1.95±0.342

1.16±0.28 c

Carnosine
content
(db)
2.61±0.65 c

Gizzard

19.99 ± 0.13

80.01 ± 0.13

17.6±1.06

0.76±.007

1.76±0.009 c

8.82±0.05 c

Liver

29.70 ± 0.11

70.30 ±0.11

19.8±0.64

1.29±0.014

102.29±1.96 a

397.26±7.58 a

Head

29.04 ± 0.44

70.96 ± 0.44

14.10±0.31

5.56±0.254

1.09±0.05 c

3.75±0.16 c

Brain

18.64 ± 0.25

81.36 ± 0.25

10.7±0.96

1.58±0.135

0.95±0.35 c

2.92±0.3 c

Lungs

17.78 ± 0.33

82.22 ± 0.33

13.2±0.46

0.88±0.030

14.41±0.73 b

81.05±4.10 b

Heart

26.04 ± 0.58

73.96 ± 0.58

16.0±1.22

0.96±0.071

2.07±0.16 c

7.96±0.58 c

1

1. HPLC method was used for determination of carnosine content; carnosine content is expressed in mg/gm of original
sample on dry weight basis. Wb= wet basis and db= dry basis.
2: All values are Mean ± SEM (N=3)
3: Fisher’s Least Significant Difference Test was used to compare mean values; a-c similar letters indicate that the
means values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are
significantly different (p ≤ 0.05).
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Table 3.3: TBARS inhibition and metal chelating activity of ultrafiltrate

Tail

Carnosine content TBARS Inhibition 1 Metal Chelating Activity 2
(mg/ml)
(%)
(%)
3
4, b
3.44±0.75
20.87±2.55 (6.06)
71.97±0.49(20.92) c

Gizzard

4.02±0.67

26.52±0.85(6.59) b

23.54±0.83(5.85) f

Liver

64.11±0.16

39.57±1.53(0.61) a

85.99±0.91(1.34) b

Head

3.11±0.01

27.59±1.85(8.87) b

94.81±0.39(30.48) a

Brain

4.32±0.46

No activity detected

86.59±0.94(20.04) b

Lungs

10.89±0.10

26.67±0.97(2.44) b

53.35±0.92(4.89) d

Heart

5.03±0.36

20.91±2.25(4.15) b

45.36±1.52(9.02) e

Carnosine 2.39±0.06

11.09±2.76(4.64) c

94.93±4.6 (39.72) a

Sample

1: % TBARS inhibiton = {(MDA without extract-MDA with extract) / MDA without extract} x100
2: % Metal chelating activity= {1- absorbance of the sample at 562nm/ absorbance of control at 562nm} x 100
3: All values are Mean ± SEM (N=4)
4: Values in the brackets are comparisons of antioxidant test value to carnosine content of the respective tissue sample.
5: Fisher’s Least Significant Difference Test was used to compare mean values; a-c similar letters indicate that the
means values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are
significantly different (p ≤ 0.05).
6: Carnosine was used as standard for comparison.
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Table 3.4: TBARS inhibition and metal chelating activity of reconstituted dry powder (25mg/ml)

Tail

Carnosine content TBARS Inhibition 1
(mg/ml)
(%)
3
3.02±0.74
5.66±0.80(1.87) 4, c

Gizzard

3.49±0.02

14.47±1.94(4.14) a

60.74±2.07(17.40) e

Liver

66.29±1.26

11.31±2.01(0.17) a, b

76.60±0.59(1.15) c

Head

4.78±0.20

10.49±1.23(2.19) a, b, c 92.20±0.42(19.28) a

Brain

3.91±1.45

No activity detected

68.67±5.14(17.56) d

Lungs

30.53±1.54

8.21±1.54(0.26) b, c

83.91±1.36(2.75) b

Heart

3.86±0.28

10.72±1.51(2.77) a, b

80.32±0.83(20.80) b, c

Carnosine 2.39±0.06

11.09±2.76(4.64)a, b

94.93±4.67 (39.72) a

Sample

Metal Chelating Activity 2
(%)
82.63±2.68(27.36) b

1: % TBARS inhibition = {(MDA without extract-MDA with extract) / MDA without extract} x100
2: % Metal chelating activity= (1- Absorbance of sample at 562nm)/ Absorbance of control at 562nm * 100
3: All values are Mean ± SEM (N=4)
4: Values in the brackets are comparisons of antioxidant test value to carnosine content of the respective tissue sample
5: Fisher’s Least Significant Difference Test was used to compare mean values; a-c similar letters indicate that the
means values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are
significantly different (p ≤ 0.05).
6: Carnosine was used as standard for comparison.
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Table 3.5: Free radical scavenging and ORAC values of ultrafiltrate

Tail

Carnosine content
(mg/ml)
3.44±0.75 3

Free Radical scavenging 1
(%)
77.71±1.15(22.59) 4, a

ORAC values 2
(Trolox Equivalents)
38.34±1.45 (11.15)d

Gizzard

4.02±0.67

61.40±0.94(15.27) c

101.21±10.46 (25.18)b

Liver

64.11±0.16

79.38±0.45(1.24) a

303.11±0.82 (4.73) a

Head

3.11±0.01

30.59±0.19(9.83) e

39.50±4.34 (12.70) d

Brain

4.32±0.46

57.77±0.84(13.37) d

62.87±4.81(14.55) c

Lungs

10.89±0.10

74.57±0.27(6.85) b

100.57±12.17 (9.24)b

Heart

5.03±0.36

25.11±1.07(4.99) f

33.54±5.05 2(6.67)d

Carnosine

2.39±0.06

8.92±1.75(3.73) g

-

Sample

1: % Free radical scavenging was calculated as {(Absorbance of control at 517 – Absorbance of sample at 517)
/Absorbance of control at 517} x 100
2: ORAC Assay (Oxygen Radical Absorbing Capacity); Values are expressed in Trolox equivalents (TE) per gram of
original sample (dry basis).
3: All values are Mean ± SEM (N=4)
4: Values in the brackets are comparisons of antioxidant test value to carnosine content of the respective tissue sample
5: Fisher’s Least Significant Difference Test was used to compare mean values; a-g similar letters indicate that the
means values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are
significantly different (p ≤ 0.05).
6: Carnosine was used as standard for comparison.
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Table 3.6: Free radical scavenging and ORAC values of reconstituted dry powder (25mg/ml)

Tail

Carnosine content
(mg/ml)
3.02±0.74 3

Free Radical scavenging 1
(%)
78.43±1.43(25.97) 4, b

ORAC values 2
(Trolox Equivalents)
21.77±0.33(7.21) e

Gizzard

3.49±0.02

74.04±0.23(21.21) c

71.49±3.91(20.48) c

Liver

66.29±1.26

84.05±0.45(1.26) a

232.08±6.02 (3.50) a

Head

4.78±0.20

67.59±0.16(14.14) d

15.76±0.19 (3.30) e

Brain

3.91±1.45

29.76±0.68(7.61) e

33.23±0.89 (8.49)d

Lungs

30.53±1.54

73.24±1.06(2.39) c

86.88±4.70 (2.85)b

Heart

3.86±0.28

77.78±0.39(20.15) b

35.72±0.95(9.25) d

Carnosine

2.39±0.06

8.92±1.75(3.73) f

-

Organ

1: % Free radical scavenging was calculated as {(Absorbance of control at 517 – Absorbance of sample at
517)/Absorbance of control at 517} x 100
2: ORAC Assay (Oxygen Radical Absorbing Capacity); Values are expressed in Trolox equivalents (TE) per gram of
original sample (dry basis).
3: All values are Mean ± SEM (N=4)
4: Values in the brackets are comparisons of antioxidant test value to carnosine content of the respective tissue sample
5: Fisher’s Least Significant Difference Test was used to compare mean values; a-f similar letters indicate that the means
values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are significantly
different (p ≤ 0.05).
6: Carnosine was used as standard for comparison.
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Table 3.7: Mineral Composition of ultrafiltrate

Sample

Mineral Composition (ultrafiltrate) pm
P

Tail

K

Ca

Mg

Zn

Cu

Mn

383.46 1021.65 45.34 37.28 0.08 0.07 0

Gizzard 237.98 903.55

Fe

S

Na

B

Al

0.03 113.89 364.02 0.09 0.01

18.11 27.83 0.52 0.01 0.08 0.14 146.46 300.51 0.07 0

Liver

529.17 1022.51 10.59 48.45 0.95 0.03 0.44 2.89 223.93 332.30 0.05 0

Head

134.64 604.74

25.14 16.11 0.04 0.17 0

0.06 167.9

461.14 0.07 0

Brain

265.01 850.09

10.39 18.39 0.03 0.07 0

0.07 68.24

405.3

Lungs

172.89 501.68

9.48

16.02 0.09 0.06 0.03 0.11 115.61 279.26 0.05 0

Heart

251.19 757.58

8.75

30.07 0.07 0.03 0.02 0.16 270.17 403.15 0.06 0
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0.1

0.02

Table 3.8: Mineral Composition of reconstituted dry powder

Sample

Mineral Composition (reconstituted dry powder) ppm
P

Tail

K

760.32 1831.1

Ca

Mg

84.66 71.4

Zn

Cu

0.12 0.08 0

Gizzard 603.94 2153.52 36.46 63.82 1.28 0.2
8.78

Mn

0.2

Fe

S

Na

B

Al

0.08 204.32 758.12

0.18 0

0.82 351.66 748.88

0.22 0.04

Liver

482.18 877.78

40.88 0.64 0.02 0.36 3.6

Head

556.02 1813.44 53.6

57.06 0.14 0.32 0.04 0.18 562.04 1386.92 0.26 0.02

Brain

683.80 1900.70 26.7

45.2

Lungs

733.44 1944.34 39.84 64.74 0.38 0.3

0.22 0.88 405.66 996.38

0.22 0

Heart

700.20 2014.62 22.98 77.98 0.28 0.12 0.08 0.48 682.04 1111.4

0.18 0

0.12 0.16 0.02 0.1

84

196.18 322.02

156

0.1

0

1009.74 0.18 0

Figure 3.2: Time-temperature treatment for the maximum carnosine recovery. Gizzard,
head, liver and tail was used to extract carnosine (N=5). Time temperature treatment
80°C/10min, 80°C/15min, and 80°C/20 min was given. Treatment mean values are not
significantly different (p ≥ 0.05).
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Figure 3.3: Comparison of TBARS inhibition of ultrafiltrate as well dry powder. Data
given as Mean± SEM (N=4).

All tissue samples ultrafiltrate and reconstituted dry

powder TBARS values were significantly different (p ≤ 0.05). Carnosine was used as
standard for comparison.
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Figure 3.4: Comparison of Metal chelating activity of ultrafiltrate as well as dry powder.
Data given as Mean± SEM (N=4). Metal chelating activity of ultrafiltrate and
reconsituted dry powder were significantly different (p ≤ 0.05). Carnosine was used as
standard for comparison.
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Figure 3.5: Comparison of free radical scavenging activity of ultrafiltrate as well dry
powder. Data given as Mean± SEM (N=4).

Free radical scavenging activity of

ultrafiltrate and dry powder were significantly different (p ≤ 0.05). Carnosine was used
as standard for comparison.
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Figure 3.6: Comparison of ORAC values of ultrafiltrate as well as dry powder. Data
given as Mean± SEM (N=4). ORAC values of heart ultrafiltrate and reconstituted dry
powder were not significantly different (p ≥ 0.05); while all other tissue samples
ultrafiltrate and reconstituted dry powder ORAC values were significantly different (p ≤
0.05).
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CHAPTER FOUR
CARNOSINE PRESENCE IN POULTRY PROTEIN MEALS AND ITS
ANTIOXIDANT CAPACITY

Abstract
The aim of this research was: (1) to determine if carnosine is present in poultry
protein meals and (2) to determine its antioxidant properties using different methods.
Sample-A and sample-G were two poultry protein meal samples obtained from two
different rendering facilities. Carnosine was extracted using hot water and analyzed by
HPLC. Antioxidant properties of extracted carnosine were evaluated using TBARS
inhibition, metal chelating activity, free radical scavenging activity, and ORAC assay.
Carnosine content of sample-G was almost 2.6 times higher (104.71 mg/100g of dry
sample) than sample–A (40.28 mg/100g of dry sample) (p≤0.05). TBARS inhibition by
sample-G was 15.86% while sample-A did not exhibit any TBARS inhibition. Metal
chelating activity and free radical scavenging activities of sample-A and sample-G did
not differ (p≥0.05); sample-A (64.16% and 81.41%) and sample-G (63.78% and 84.17%)
respectively. ORAC values (µM TE /gm of dry sample) of sample-A (84.35) were
greater than sample-G (68.44) (p≤0.05). Overall, carnosine was present in poultry protein
meals, and retained its antioxidant properties after high temperature rendering (~115°C).
Abbreviations: ORAC = Oxygen Radical Absorbing Capacity; TBARS= Thiobarbituric
Acid Reactive Species; TE= Trolox Equivalents
Keywords: Carnosine, Poultry protein meal, antioxidant, ORAC, TBARS
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4.1 Introduction
In the US, there are approximately 300 rendering plants which produce various
products including lard, grease, animal and marine protein meals and meat and bone meal
generating an annual revenue of $2.8 billion (Economic Census-2002, US Census Bureau
report). According to Swisher (2009), 8.7 billion chickens were slaughtered in US
resulting in production of 2.4 billion pounds of poultry byproduct meal, 1.3 billion
pounds of poultry fat and 1.2 billion pounds of feather meal.
Rendering is a process that “cooks” inedible by-products of the meat and poultry
industry at high temperatures (115°C to 137°C). After cooking, fat is separated to
produce lard, grease and tallow with the remaining by-product being pressed to produce
protein meal.

Poultry protein meal is defined as a dry rendered product from a

combination of clean flesh and skin with or without accompanying bone, derived from
parts of whole carcasses of poultry or combination thereof, exclusive of feathers, heads,
feet and entrails (AAFCO, 2004).
Antioxidant activity of poultry meal is an index of its oxidative stability. With
oxidation, the product will lose its sensory and nutrition quality attributes and may result
in the formation of toxic compounds posing potential health concerns. Toxic compounds
formed by oxidation reactions can lead to several diseases such as atherosclerosis,
cytotoxicity, mutagenesis and carcinogenesis (Gray et al., 1996).
There are concerns about the use of synthetic antioxidants such as ethoxyquin,
butylated hydroxy anisole (BHA), and butylated hydroxy toluene (BHT) in poultry
protein meals due to the toxicity above certain limits (Branen, 1975; Ito, et al., 1986) .
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Thus, there is a need to explore antioxidants naturally present in poultry protein meals,
which could replace/minimize the use of synthetic antioxidants. In a recent article,
Aldrich (2007) stated a need for natural water soluble antioxidants that could be applied
in the processing environment.
Carnosine does not have any known toxic effects and excess carnosine is excreted
in the urine (Perry et al., 1967). Furthermore, there are no reports of toxic effects of
carnosine derivatives (Quinn et al., 1992; Sato et al., 2008). Carnosine is a water soluble
dipeptide composed of β-alanine and L-histidine. It acts as a buffer (Davey, 1960;
Skulachev, 2000; Smith, 1938) and antioxidant (Chan et al., 1994; Kohen et al., 1988) in
muscle, aids in muscle contraction (Avena and Bowen, 1969; Severin et al., 1963) acts as
a neurotransmitter in brain (Trombley et al., 2000; Tomonaga et al., 2004; Tomonaga et
al., 2005), regulates calcium proteins in cardiac muscles (Roberts and Zaloga, 2000),
possess anti-ageing effects (Hipkiss, 1998; Hipkiss and Brownson, 2000; Reddy et al.,
2005) and chelates metal ions (Baran, 2000; Chan and Decker, 1994; Kohen et al.,
1988). Carnosine was isolated from beef muscle in 1900 (Guelwitsch and Amiradgibi,
1900; Guelwitsch, 1906) and since then carnosine has been extracted and studied in a
variety of animals. For example, carnosine was extracted from mammalian skeletal
muscle of cat, dog, deer, gnu, oppossum and llama (Wolff and Wilson, 1935) and turkey
(Davis et al., 1978). Carnosine is present as high as 20 mM in mammalian skeletal
muscles and in lower levels in the central nervous system (Guiotto et. al., 2005).
Carnosine has been extracted from mechanically deboned pork (Gopalakrishnan et al.,
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1999), poultry breast (Maikhunthod et al., 2005) and from isolated muscle protein waste
material (James et al., 1995).
Several researchers have reported various modes of antioxidant activity for
carnosine. It acts as a metal chelator, reactive oxygen scavenger, free radical scavenger
and peroxide decomposer (Baran, 2000; Chan and Decker, 1994; Reddy et al., 2005;
Decker and Faraji, 1990). Very little information is available on the extraction of
antioxidants such as carnosine from poultry meals. Therefore, the objective of the present
research was to determine the concentration of carnosine from different poultry protein
meals as well as to measure its antioxidant properties using different antioxidant
methods.

4.2 Materials and Methods

4.2.1. Materials
Trolox- [(±)- 6-hydroxy-2, 5, 7, 8- tetramethyl-chroman-2-carboxylic acid; CAS#
53118-07-1], ferrous chloride [CAS# 7758-94-3], ferrozine [3-(2-pyridyl)-5,6-diphenyl1,2,4-triazine-4’,4”-

disulfonic

acid

sodium

salt;

CAS#69898-45-9],

TCA

[

trichloroacetic acid; CAS# 76-03-9], DPPH [2,2-diphenyl-1-picryl-hydrazyl; CAS#
1898-66-4], fluorescein sodium salt [CAS# 518-47-8], 2-thiobarbituric acid [CAS# 50417-6], L- carnosine [CAS # 305-84-0],

OPA [phthaldialdehyde reagent; Product #

057K5015], L-α-phosphatidylcholine Type IV-S [CAS# 8002-43-5], AAPH [ 2,2’93

azobis (2-methylpropion-amidine) dihydrochloride 97% ; CAS # 2997-92-4] and TEP
[3,3,3-tetarethoxypropane; CAS# 122-31-6] were purchased from Sigma Aldrich (St.
Louis, Missouri, USA).
Sodium acetate trihydrate [CAS# 6131-90-4], methanol- HPLC grade (0.2µm
filtered) [CAS # 67-56-1], acetonitrile- HPLC grade (0.2µm filtered) [CAS # 75-05-8]
were purchased from Fisher Scientific (Fair-lawn, New Jersey, USA) while L-ascorbic
acid sodium [ CAS # 134-03-2 was purchased from Arcos Organics (New Jersey, USA)
while BHT [butylated hydroxytoluene] CAS# 128-37-0 was purchased from MP
Biomedical, Inc (Solon , Ohio, USA). All reagents were ACS grades or purer.

4.2.2. Sample Procurement
Pet grade poultry protein meal samples, sample-A and sample-G were obtained
from two different rendering facilities without added stabilizers. Carnosine was extracted
using a hot water procedure described by Maikhunthod et al., (2005) with slight
modifications (Figure 4.1). Briefly, one part of ground poultry protein meal sample was
added to six parts of pre-cooled (4°C) nano pure water and samples were homogenized in
a Osterizer Blender (Model # 4937, Sunbeam Products Inc., Boca Raton, FL, USA) using
4 cylcles of 2min each cycle with 2 min cooling with ice slush between each cycle (8 min
total homogenization). The homogenate was centrifuged at 20,000 g for 30 min at 4°C in
Sorval RC-5B refrigerated super speed centrifuge (Du-Pont Instruments, Wilimgton, DE,
USA); the supernatant was then filtered through Whatman #4 filter paper (GE Healthcare
Bio-Sciences Corp., Piscataway, New Jersey, USA). The water extracted filtrate
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(supernatant) was subjected to heat treatment at 80°C for 15 min in a jacketed water bath
(Precision, Model#283, Thermo scientific, Winchester, VA, USA), followed by cooling
in ice water for 5 min. The heat extract was centrifuged to remove precipitated proteins at
6000 g for 20 min then the supernatant was filtered through Whatman #4 filter paper.
The collected supernatant was then ultrafiltered using Amicon Ultra-15 filter
device (Catalog # UFC900324, Millipore, Billerica, MA, USA) with 3000 molecular
weight cut off, using centrifugal force of 4000g for 55 min at 14°C in Beckman Model J6B centrifuge (Beckman Coulter Inc., Brea, CA, USA). The ultrafiltration permeate was
collected and stored at -80 °C until further analysis.
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Poultry meal sample

Homogenize

First Centrifuge at 20000 g for 30min at 4°C

Filter

Heat treatment 80°C for 15min (supernatant)

Second centrifuge at 6000 g for 20min at 4°C

Filter

Extract (supernatant)

Ultra-filtration 3000 MWCO at 4000 g for 55min

Ultra filtrate

Figure 4.1: Flow Chart of extraction Procedure
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4.2.3. Determination of carnosine by HPLC Method
Carnosine content was measured by HPLC as described by Gopalakrishnan et al.,
(1999) and Maikhunthod et al. (2005) with slight modifications. 2 ml of 0.4M perchloric
acid was added to 2 ml of poultry protein meal ultrafiltrate. The mixture was vortexed
(Vortex Genie 2

TM

, Model# G-560, Fisher Scientific, Bohemia, New York) and boiled

for 10 min (to precipitate proteins) and then centrifuged at 5000g for 5 min at 4°C in
Sorval RC-5B refrigerated super speed centrifuge (Du-Pont Instruments, Wilimgton, DE,
USA). After centrifugation, the supernatant was filtered through 0.45 µm membrane
filter. Filtrate was derivatized using OPA by adding 100 µl of OPA to 500 µl of sample,
just prior to injection into HPLC (Shimadzu Instruments, Columbia, MD, USA).
OPA derivatized carnosine was separated using a mobile phase of 0.3M sodium
acetate (pH 5.5), methanol and acetonitrile (75:15:10) at a flow rate of 0.75 ml/min with
Waters Spherisorb SCX-4.6x250 mm column (Waters Corporation, Milford, MA, USA).
Derivatized carnosine was detected using fluorescence (RF551 Spectroflurometric
detector, Shimadzu Instruments) with an excitation wavelength of 310 nm and emission
wavelength of 375 nm. The standard curve was prepared using a carnosine solution
(5– 80mM). The retention time and peak areas were analyzed by EZ start 7.4 Software
provided with the equipment (Shimadzu Instruments, Columbia, MD, USA).
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4.2.4. TBARS Inhibition
TBARS inhibition was analyzed using a phosphatidyl choline emulsion system, as
described by Kansci et al. (1997) and Gopalkrishnan et al. (1999). TBA/TCA reagent was
prepared by a method described by Tarladgis et al. (1960). Two mg/ml phosphatidyl
choline emulsion was prepared in a 5mM phosphate buffer pH 7.0 using Polytron®
PT2100 homogenizer (Capitol Scientific Inc., Austin, Texas, USA). The phosphatidyl
choline emulsion (1.8 ml) was mixed in 0.5 ml of sample and held at room temperature
for 5 min to allow sample to react with the emulsion. After 5 min, the emulsion oxidation
was initiated using catalyst FeCl2 (50 µl) and sodium ascorbate (100 µl) to the final
concentration of FeCl2 and sodium ascorbate of 40µM each in emulsion system.
The polypropylene tubes (BD Falcon, Mississauga, ON, Canada) containing
mixture were incubated at 37°C in a water bath (Precision, Model#283, Thermo
scientific, Winchester, VA, USA) and after 2 hours the reaction was stopped by adding
50 µl of 10% BHT solution. To each tube, 2.5ml of TBA/TCA solution was added and
vortexed with Vortex Genie 2 TM (Model# G-560, Fisher Scientific, Bohemia, New York)
followed by heating in water bath at 90°C for 15 min. After heat treatment, the tubes
were cooled down under running tap water and then centrifuged at 5000 g for 15 min at
4°C in Sorval

RC-5B refrigerated super speed centrifuge (Du-Pont Instruments,

Wilimgton, DE, USA).
Absorbance was read at 531 nm using a spectrophotometer (Genesys 20, Model
#4001/4; Themofisher Scientific, New Jersey, USA) and water was used as a blank.
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MDA (malondialdehyde) was calculated using standard curve prepared from TEP (1, 1,
3, 3,-tetraethpxypropane) at concentrations from 0 to 70 nM MDA. All reagents were
prepared fresh daily prior to experimentation. Emulsion without extract was taken as a
negative control.
Percent TBARS Inhibition was calculated using following formula:{(MDA without extract-MDA with extract) / MDA without extract} x100

4.2.5. Free radical scavenging assay
Free radical scavenging assay was performed as described by Yen et al. (2002).
DPPH radical (0.2mM) was dissolved in absolute ethanol. 2ml of poultry protein meal
ultrafiltare was mixed with 2ml of DPPH. The mixture was allowed to stand for 30 min
in dark and the absorbance of the resultant solution was measured at 517nm with a
spectrophotometer (Genesys 20, Model #4001/4; Themofisher Scientific, New Jersey,
USA). Mixture without extract was taken as negative control and absolute ethanol was
used as a blank.
Percent free radical scavenging was calculated as {(Absorbance of control at 517
nm – Absorbance of sample at 517 nm)/Absorbance of control at 517 nm} x 100

4.2.6. Metal Chelating Activity
Chelating activity of Fe

2+

was measured using a method described by Yen and

Wu (1999). In this method, 1ml of poultry protein meal ultrafiltrate was added to 3.7 ml
of nanopure water and the mixture was reacted with 100 µl of 2mM FeCl2 and 200 µl of
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5mM ferrozine for 20 min. After 20min absorbance was measured at 562 nm using a
spectrophotometer (Genesys 20, Model #4001/4; Themofisher Scientific, New Jersey,
USA). Nanopure water was used as a blank. A negative control (sample with all reagents
but no poultry meal ultrafiltrate) was used for calculations and the percent chelation was
calculated using formula:{1- absorbance of the sample at 562 nm/ absorbance of control at 562 nm} x 100

4.2.7. ORAC Assay
Oxygen radical absorbing capacity (ORAC) was determined by a hydrophilic
method described by Wu et al. (2008). The poultry protein meal samples were diluted
100 times with phosphate buffer (pH 7.4). Twenty five microliter of the diluted sample or
Trolox standard solution (0, 10, 20, 40, 60,100µM) or blank (phosphate buffer pH 7.4)
was added to one of 96 well plates (black with clear bottom, Optilux

TM

, BD Falcon).

Flourescein solution (150µl) of 0.004 µM concentration was added to each well and the
microplate was incubated at 37°C for 30 min in VWR-Incubating mini shaker
(Model#980150, VWR, Arlington Heights, IL, USA). After 30 min incubation at 37°C,
25µl of AAPH solution (153mM) was added to each well (as the peroxyl generator)
using auto injector (BioTek Instruments, Inc. Winnooski, Vermont, USA) to inititate the
reaction. The microplate reader Synergy-HT from BioTek Instruments, Inc (Winnooski,
Vermont, USA) was programmed to measure fluorescence at an excitation wavelength of
485 nm and an emission wavelength of 520nm at 1min time intervals for 1 hr and ORAC
values were calculated using software Gen5TM ( BioTek Instruments, Inc. Winnooski,
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Vermont, USA). The data were expressed as Trolox equivalents (TE) per gram of
original sample (dry basis).

4.2.8. Total Mineral Content
Standard mineral content in a poultry protein meal was measured from
ultrafiltrate samples diluted 1:10 before measurment.

Samples were sent to the

Agricultural Services Laboratory at Clemson University where mineral content was
determined using inductively coupled plasma spectrometer (SPECTRO ARCOS- ICP,
Kleve, Germany).

4.2.9. Protein Content
Poultry protein meal samples were sent to Agricultural Services Laboratory at
Clemson University where protein content was determined with Dumas method described
in the Official Methods of Analysis, section 968.06 (AOAC, 1990) using nitrogen/protein
analyzer (LECO Model# FP 528 ,Warrendale, PA, USA) .

4.2.10. Statistical Analysis
ANOVA was performed to determine overall differences in the group means. To
determine specific differences between pairs of group means, the Fisher LSD test was
used. Both tests used a Type I Error probability of 0.05 and the SAS (Statistical Analysis
Software Edition 9.2, SAS Institute Inc., 2007) was used to perform the statistical
calculations.
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4.3. Results and Discussion
4.3.1. Proximate composition and Carnosine Content
Sample-A showed higher (p≤0.05) moisture and protein content than sample-G
(Table 4.1). Ash content of sample-A did not differ (p ≥0.05) from sample-G. In addition,
total mineral content of sample-A was higher than sample-G (Table 4.2).
Standard pet food grade contains less than 14% ash while low ash poultry meal or
poultry by product meal contains 11% or less ash (Aldrich, 2007). In present study, ash
content of poultry protein meal samples were greater than 11%, indicates that the samples
were pet grade. Feed grade is seldom used in pet food because it contains lower levels of
protein and higher levels of ash (Aldrich, 2007).
Carnosine content in poultry protein meal sample-G was nearly 2.6 times higher
(p≤0.05) than that of sample–A (Table 4.1). Presence of carnosine in the meat and bone
meal, fish meal and feather meal has been determined using HPLC (Schonherr 2002)
whose primary objective was to develop a reliable and cost effective analytical method.
This study revealed the carnosine presence in different animal origin feeds, and also
indirectly hinted as to carnosine integrity after high temperature processing (~115°C).
Carnosine content results in the current study were in agreement with Schonherr (2002).

Antioxidant Activity Analysis
There is no one standardized method to measure all aspects of antioxidant activity
and for this reason different methods for measuring antioxidant activity under various
oxidation conditions approach was employed (Di Bernardini et al., 2011; Zulueta et al.,
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2009; Frankel and Meyer, 2000). The antioxidant activity of poultry protein meal
ultrafiltrate was measured using thiobarbituric acid reactive species (TBARS) inhibition,
ORAC, metal chelating and DPPH radical scavenging assay.

4.3.2. TBARS Inhibition
TBARS primarily measures the malondiadehyde (MDA) content, an abundant
product of lipid oxidation as well as other secondary products of the oxidation reaction.
TBARS inhibition of Sample-G (15.86%) was slightly greater than carnosine-10mM
standard (11.09%); however this difference was not significant at the 5% level. SampleA did not exhibit any TBARS inhibition (Table 4.3). Overall comparison of percent
TBARS inhibition, free radical scavenging and metal chelation of poultry meal samples
were compared in Figure 4.2.
Inhibition of TBARS by poultry protein meal in our study was lower than those
reported by Maikhunthod and Intarapichet (2005) for broiler’s breast and thigh
ultrafiltrate. These differences in results between poultry protein meal and similar raw
tissues may be due to source differences, concentrations of phosphatidyl choline
emulsion in the system, and the variation in catalysts (FeCl2 and sodium ascorbate)
levels. Further, some enzymes which impart antioxidant activity similar to carnosine
such as superoxide dismutase, catalase or glutathione oxidase and glutathione reductase
(Sacchetti et al., 2008 and Chan et al., 1994) may be denatured or lose activity to
different degrees during the high temperature rendering process. TBARS inhibitions
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found in the current study were similar to values reported for mechanically separated
pork extract (Gopalakrishnan et al., 1999).
Carnosine is known to form complexes with certain divalent metal ions such as
Co, Cu, Mn, Zn, Cd, while K, Mg, Ca, Na do not bind with carnosine (Boldyrev, 2007).
The metal ions already present (Co, Cu, Mn, Zn, Cd) in the extract might promote this
reaction or act as proxidants (when added into the emulsion system of phosphatidyl
choline) and thus, can lead to interference of the results. Poultry meal contains amino
acids such as histidine, lysine, methionine, tryptophan, tyrosine and cystein (Aldrich,
2007), all of which have antioxidant properties.
Aromatic amino acids such as histidine, tyrosine and tryptophan can donate
protons or electrons to scavenge radicals and stop the oxidation reaction while nonaromatic amino acids such as methionine, lysine and cysteine can interact directly with
radicals (Sarmadi and Ismail, 2010).

Other hydrophilic antioxidants such as small

peptides like anserine, homocarnosine, uric acid and ascorbates may be present in the
poultry meal (Sacchetti et al., 2008). Moreover, protein denaturation due to

high

temperature (~115°C), may cause changes in amino acid sequences of histidine and other
amino acids such as lysine and proline to form new peptides (for example P-H-H or L-LP-H-H) (Di Bernardini et al., 2011) which can provide antioxidant properties in poultry
protein meal. Water soluble molecules (amino acids and other small peptides) are also
extracted with carnosine. Thus, it is likely that these substances along with carnosine
(present in extract) contribute to the antioxidant activity of poultry protein meal.
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4.3.3. Metal Chelating Activity
Metal chelating activity of carnosine-10mM standard was higher (p≤0.05) than
that of sample-A and sample- G (Table 4.3). Sample–A and sample-G metal chelating
activity did not differ (p≥ 0.05).
Carnosine acts as a metal chelator and interrupts oxidation reactions (Baran,
2000). Carnosine forms complexes with Fe2+. Amino acids such as histidine also form
complexes with Fe2+ which can results in a mixed ligand formation (Boldyrev, 2007) and
can alter metal chelation values.
Therefore, as suggested by various scientists, the removal of proxidants such as
iron will increase antioxidant activity of protein extracts (Chan et al., 1993;
Gopalakrishnan et al., 1999; Maikhunthod and Intarapichet, 2005). So, for a more
accurate evaluation of the antioxidant activity of carnosine in poultry meal,
demineralization could be an option. However, for commercialization the addition of
demineralization step would add cost to the final product.

4.3.4. Free Radical Scavenging (DPPH)
DPPH assay is based on electron donation by antioxidants to stabilize the electron
deficient DPPH radical. Free radical scavenging activity of sample-G and sample-A was
greater (p≤0.05) than that of the carnosine-10mM standard, while sample-A and sampleG did not differ (p≥ 0.05) (Table 4.3).
Besides carnosine, aromatic amino acids (such as histidine, tyrosine and
tryptophan) can donate proton or electron to deficient radicals and also interrupt the
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oxidation reaction. Cysteine, a non-aromatic amino acid can directly interact with
radicals (Sarmadi and Ismail, 2010) while polyamines also contribute radical scavenging
activity (Sacchetti et al., 2008) . Thus, carnosine is not only the component in protein
meal that can impact free radical scavenging activity.

4.3.5. ORAC Values
ORAC assay is based on hydrogen atom donation by antioxidants to stabilize
peroxyl radicals produced by AAPH. In this method, the ORAC values are obtained from
kinetic curves derived from competitive kinetic reactions (Huang et al., 2005). Sample-A
ORAC values (µM Trolox Equivalents/gm of dry sample) were higher (p≤0.05) than
those of sample-G (Table 4.3).
ORAC values of poultry protein meal ultrafiltrates were higher than those of
hydrophilic extract of beef samples obtained by Wu et al., (2008). Kohen et al., (1988)
determined antioxidant activity of carnosine, homocarnosine and anserine against peroxyl
radicals

by

using

voltametric

measurements

in

AMVN

{2,2-azobis

(2,4-

dimethylvaleronitrile)} and AAPH {2,2’-azobis(2-amidino-propane dihydrochloride)}
systems under physiological conditions. They also compared different structures such as
carnosine, anserine, GABA {γ-amino butyric acid}, L-alanine, β-alanine and found that
carnosine has 53% inhibition against peroxyl radicals while anserine showed 39% and
GABA, L-alanine, β-alanine showed no inhibition. Histidine displayed 42% while
histamine showed 28% inhibition against peroxyl radicals due to donation of hydrogen
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atom to the peroxyl radicals. Our samples might contain other dipeptides such as
anserine, homocarnosine which interact with peroxyl radicals in similar way as carnosine.
Several researchers have reported various modes of antioxidant activity for carnosine. It
acts as a metal chelator, reactive oxygen scavenger, free radical scavenger and peroxide
decomposer (Baran, 2000; Chan and Decker, 1994; Reddy et al., 2005). Carnosine also
possesses antioxidant properties due to the imidazole moiety in its structure (Aruoma et
al., 1989; Boldyrev et al., 1993; Boldyrev et al., 1997; Hartman et al., 1990; Kohen et al.,
1988; Quinn et al., 1992)
From the current study, and one by Kansci et al., (1997) it can be concluded that
carnosine antioxidant activity is multifunctional; It chelates metal ions, decreases free
radicals and reacts with secondary oxidation products.

4.4. Conclusions
Besides antioxidant properties, carnosine has other potential therapeautic as well
as medicinal values. Carnosine exhibits anti-ageing effect (Hipkiss, 1998; Hipkiss and
Brownson, 2000; Reddy et al., 2005), reduces physiological oxidative stress (Boldyrev,
2007), aids wound healing and inhibits inflammation (Boldyrev and Severin, 1990;
Nagai, 1980). Chelating properties of carnosine against metal ions (Baran, 2000; Chan
and Decker, 1994; Kohen et al., 1988) can be exploited to cure Wilson’s disease (by
chelation of Cu ions). Carnosine is a potential cure for senile cataracts (Babizhayev et
al., 2009) and Alzheimer’s disease (Reddy et al., 2005).
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Buffering properties of

carnosine in muscle (Davey, 1960; Skulachev, 2000; Smith, 1938) improve high intensity
exercise performance and endurance in humans (Sato et al., 2003). Carnosine zinc
complex (L-CAZ, generic name Polaprezinc) is the first drug administered orally for antiulcer effect due to its membrane protection ability (Matsukura and Tanaka, 2000).
Carnosine extraction from poultry meal using hot water would have a relatively
low manufacturing cost having excellent solubility in pet food and easy digestion in
animals. Moreover, there is an increasing demand of producing novel functional foods
containing bioactive peptides such as carnosine, anserine and L-carnitine (Arihara, 2006).
Therefore, it can be concluded that extraction of carnosine from poultry meal may have a
positive economical impact by increasing revenue for the rendering industry.

By

carnosine incorporation, potential therapeutic pet food could be exploited to benefit
animal health.
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TABLES and FIGURES

Table 4.1: Proximate Composition of Poultry Protein Meals
Sample

Moisture
Content (%)

Protein
Content (wb) 1
(%)

Protein
content (db)
(%)

Ash Content
(%)

Carnosine
Content (wb)

Sample-A 4.96±0.06 a

67.6±1.48 a

70.1±1.48 a

13.28±0.16a

38.28±0.46

Sample-G 2.16± 0.07 b

65.4±2.03 b

69.4±2.03a

12.76±0.20a

102.44±10.06b

Carnosine
Content (db)

1, 3
a

40.28±0.49a
104.71±10.28b

1. HPLC method was used for determination of carnosine content; carnosine content is expressed in mg/ 100 gm of
original sample. Wb= wet basis and db= dry basis.
2: All values are Mean ± SEM (N=3)
3: Fisher’s Least Significant Difference Test was used to compare mean values; a-b similar letters indicate that the means
values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are significantly
different (p ≤ 0.05).
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Table 4.2: Mineral Composition of Poultry Protein Meals 1

Sample

Sample-

Mineral Composition
P

K

Ca

Mg

Zn

Cu

Mn

Fe

S

Na

B

Al

546.29

1686.21

62.32

71.85

0.22

0.05

0.03

0.66

292.34

769.26

0.24

0.02

398.14

1247.28

42.28

47.85

0.08

0.10

0.02

0.55

221.67

751.99

0.16

0.18

A
SampleG
1: Concentrations are parts per million (ppm) on dry basis.
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Table 4.3: Antioxidant Activity Tests
Sample
TBARS Inhibition (% ) 1

Antioxidant Activity Test
Metal Chelation (%) 2
Free Radical
Scavenging (%) 3
64.16±5.12a
81.41±0.19a

ORAC Values
84.35±0.34a

Sample-A

No activity detected

Sample-G

15.86±2.01

a

63.78±4.53a

84.17±0.50 a

68.44±1.36b

Carnosine10Mm

11.09±0.98 a

94.93±1.65b

8.93±1.75 b

Not Determined

1)
2)
3)
4)
5)

4

All values are Mean ± SEM (N=4); ND= Not determined
a, b means within columns with different superscripts are significantly different (p ≤ 0.05)
% TBARS Inhibition= {(MDA without extract-MDA with extract) / MDA without extract} x100
% Metal chelating activity= {1- absorbance of the sample at 562nm/ absorbance of control at 562nm} x 100
% Free radical scavenging was calculated as {(Absorbance of control at 517 – Absorbance of sample at 517)/Absorbance of
control at 517} x 100
6) ORAC Assay (Oxygen Radical Absorbing Capacity); Values are expressed in Trolox equivalents (TE) per gram of original
sample (dry basis).
7) Fisher’s Least Significant Difference Test was used to compare mean values; a-b similar letters indicate that the means values are
not significantly different (p ≥ 0.05); while different letters indicate that the mean values are significantly different (p ≤ 0.05).
8) Carnosine was used as standard for comparisons.
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b

a

a
a

a

a

a

b

Figure 4.2: Antioxidant activities of poultry meal using different antioxidant methods.
Carnosine was used as standard for comparison. Different letters indicate that the values
are significantly different (p ≤ 0.05).
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CHAPTER FIVE
ANTIOXIDANT ACTIVITIES OF CARNOSINE AND ITS CONSTITUENT AMINO
ACIDS IN DIFFERENT MODEL SYSTEMS

Abstract
The present study compared carnosine with its constituent amino acids, β-alanine
and L-histidine as well as with imidazole to elucidate the antioxidant mechanism of
carnosine and its components. Concentrations ranging from 5 to 100 mM of carnosine, Lhistidine, β-alanine and imidazole were prepared and antioxidant activity assays (TBARS
inhibition, metal chelating activity, free radical scavenging activity) were conducted.
Our results indicate that TBARS inhibition of carnosine was due to the imidazole ring
present in the histidine and with no inhibition contributed to β-alanine. Metal chelating
properties of carnosine was also due to the imidazole ring and not to histidine or βalanine, while free radical scavenging activity of carnosine was attributed to histidine
amino acid and not due to imidazole and β-alanine.
Overall, results indicate that β-alanine and the peptide bond present between Lhistidine and β-alanine do not play any role in antioxidant activity of carnosine.
Furthermore, we determined that the imidazole has antioxidant properties alone,
therefore, could be used as an antioxidant in various food and feed applications.
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5.1 Introduction
Carnosine is a water soluble dipeptide composed of β-alanine and histidine that
includes imidazole (Figure 1a, 1b, 1c, 1d). Histidine is an essential amino acid for
humans while β-alanine is non-essential amino acid being synthesized in liver as a final
product of uracil and thymine degradation (Matthews and Traut, 1987). Carnosine acts
as a buffer in muscle tissue (Davey, 1960; Skulachev, 2000; Smith, 1938), a potent
antioxidant in skeletal muscles (Chan and Decker, 1994; Kohen et al., 1988), aids in
muscle contraction (Avena and Bowen, 1969; Severin et al., 1963) and acts as a
neurotransmitter in brain (Trombley et. al, 2000; Tomonaga et al., 2004; Tomonaga et al.,
2005). Futhermore, carnosine is a regulator of calcium proteins in cardiac muscles
(Roberts and Zaloga, 2000), possesses anti-ageing effect (Hipkiss, 1998; Hipkiss and
Brownson, 2000; Reddy et al., 2005) and a chelating agent of metal ions (Baran, 2000;
Chan and Decker., 1994; Kohen et al., 1988).

Various mechanisms of carnosine

antioxidant activity have been reported, including metal chelation, reactive oxygen
scavenging, free radical scavenging and peroxide decomposing (Baran, 2000; Chan and
Decker., 1994; Kohen et al., 1988). The structure-function relationships of carnosine
indicates that the imidazole moiety of carnosine and the peptide linkage between histidine
and β-alanine are responsible for its antioxidant activity (Aruoma et al.,1989; Boldyrev et
al., 1993; Boldyrev et al., 1997; Hartman et al., 1990; Kohen et al., 1988; Quinn et al.,
1992).
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The present study compared carnosine with its constituent amino acids, β-alanine
and L-histidine as well as with imidazole to elucidate the antioxidant mechanisms of
carnosine and its constituent amino acids.

Figure5.1a: Two dimensional structure of carnosine 5.1 b: Two dimensional structure of histidine

5.1d: Two dimensional structure of β-alanine

5.1c: Two dimensional structure of imidazole
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5.2. Materials and Methods
5.2.1. Materials
Ferrous chloride [CAS# 7758-94-3], ferrozine [3-(2-pyridyl)-5,6-diphenyl-1,2,4triazine-4’,4”- disulfonic acid sodium salt; CAS#69898-45-9], TCA [ trichloroacetic acid;
CAS#

76-03-9],

DPPH

[2,2-diphenyl-1-picryl-hydrazyl;

CAS#

1898-66-4],

2-

thiobarbituric acid [CAS# 504-17-6], L- carnosine [CAS # 305-84-0], L-histidine [CAS#
71-00-1],

β-alanine

[CAS#

203-536-5]

Imidazole

[CAS#288-32-4],

L-α-

phosphatidylcholine Type IV-S [CAS# 8002-43-5], and TEP [3,3,3-tetarethoxypropane;
CAS# 122-31-6] were all purchased from Sigma Aldrich (Saint Louis, Missouri, USA).
L-ascorbic acid sodium [CAS # 134-03-2] was purchased from Arcos Organics (New
Jersey, USA) while BHT [butylated hydroxytoluene; CAS# 128-37-0] was purchased
from MP Biomedical, Inc (Solon, Ohio, USA). All reagents were ACS grades or purer.

Methods
5.2.2. Preparation of reagents
Samples of different molar concentrations (5, 25, 50, 100 mM) of L- carnosine, Lhistidine, β-alanine and Imidazole were prepared using nano pure water just prior to
experimentation. All reagents were prepared fresh daily.

5.2.3. TBARS Inhibition
Thiobarbituric acid reactive species (TBARS) inhibition was analyzed using a
phosphatidyl choline emulsion system, as described by Kansci et al (1997) and
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Gopalkrishnan et al (1999). TBA/TCA reagent was prepared by a method described by
Tarladgis et al. (1960). Two mg/ml phosphatidyl choline emulsion was prepared in 5mM
phosphate buffer (pH 7.0) using Polytron® PT2100 homogenizer (Capitol Scientific Inc.,
Austin, Texas, USA). 1.8 ml phosphatidyl choline emulsion of emulsion was mixed in
0.5 ml of sample and held for 5 min to allow interaction of carnosine or each of the
constituents (i.e. histidine, β-alanine and imidazole) with the emulsion. After 5 min, the
emulsion oxidation was intiated by adding catalyst FeCl2 (50 µl) and sodium ascorbate
(100 µl) achieving a 40µM concentration of FeCl2 and sodium ascorbate in emulsion
system.
Polypropylene tubes (BD Falcon, Mississauga, ON, Canada) containing the
emulsion were incubated at 37°C in a water bath (Precision, Model#283, Thermo
scientific, Winchester, VA, USA) and after 2 hours the reaction was terminated by adding
50 µl of 10% BHT solution. To each tube, 2.5ml of TBA/TCA solution was added and
vortexed with Vortex Genie 2 TM (Model# G-560, Fisher Scientific, Bohemia, New York)
followed by heating in water bath at 90°C for 15 min. After heat treatment, the tubes
were cooled under running tap water and then centrifuged at 5000g for 15 min at 4°C in
Sorval RC-5B refrigerated super speed centrifuge (Du-Pont Instruments, Wilimgton, DE,
USA).
Absorbance was read at 531nm using a spectrophotometer (Genesys 20, Model
#4001/4; Themofisher Scientific, New Jersey, USA) and water was used as a blank.
Malondialdehyde (MDA) was calculated using a standard curve prepared from 1, 1, 3, 3,tetraethpxypropane (TEP) at concentrations from 0 to 70 nM MDA. All reagents were
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prepared fresh daily prior to experimentation. Tubes containing reagents but without
sample were taken as a negative control.
Percent TBARS Inhibition was calculated using following formula:{(MDA without extract-MDA with extract) / MDA without extract} x100

5.2.4. Free radical scavenging assay
Free radical scavenging assay was performed as described by Yen et al. (2002).
DPPH radical (0.2mM) was dissolved in absolute ethanol. Two ml of carnosine or
histidine or β-alanine or imidazole was mixed with 2ml of DPPH and the mixture was
allowed to stand for 30 min in dark and the absorbance of the resultant solution was
measured at 517nm with spectrophotometer (Genesys 20, Model #4001/4; Themofisher
Scientific, New Jersey, USA). Mixture without sample was taken as negative control and
absolute ethanol was used as a blank.
Percent free radical scavenging activity was calculated as {(Absorbance of control at
517 nm – Absorbance of sample at 517 nm)/Absorbance of control at 517 nm} x 100

5.2.5. Metal Chelating Activity
Chelating activity on Fe 2+ was measured using the method described by Yen and
Wu (1999). In this method, 1ml of carnosine or histidine or β-alanine or imidazole was
added to 3.7ml of nanopure water and the mixture was reacted with 100 µl of 2mM FeCl2
and 200 µl of 5mM ferrozine for 20 min kept at ambient temperature. After 20min
absorbance was measured at 562nm using spectrophotometer (Genesys 20, Model
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#4001/4; Themofisher Scientific, New Jersey, USA). Nanopure water was used as a
blank. Tubes with no sample was used as a negative control
Percent chelation was calculated using formula:{1- absorbance of the sample at 562nm/ absorbance of control at 562nm} x 100

5.2.6. Statistical Analysis
ANOVA was performed to determine overall differences in the group means. To
determine specific differences between pairs of group means, the Fisher LSD test was
used. Both tests used a Type I Error probability of 0.05 and the SAS (Statistical Analysis
Software Edition 9.2, SAS Institute Inc., 2007) was used to perform the statistical
calculations.

5.3. Results and Discussion
5.3.1. TBARS inhibition
TBARS measures MDA content which is the most abundant product of lipid
oxidation and other secondary products of reaction. Carnosine, histidine and imidazole
showed a positive trend of increased inhibition with an increase in molar concentration of
each constituent (Table 5.1). Imidazole displayed the greatest inhibition followed by
histidine and carnosine (p≤0.05) at each molar concentration. L-histidine showed higher
TBARS inhibition values than carnosine at 50 and 100mM (p≤0.05) while lower TBARS
values than carnosine at 25mM (p≤0.05); the difference between carnosine and L126

histidine at 5mM concentration was not significant (p ≥0.05). β-alanine did not exhibit
TBARS inhibition at any molar concentrations tested. Results indicated that TBARS
inhibition of carnosine was due to the imidazole ring present in the histidine. Erickson
and Hultin also found that histidine inhibits lipid peroxidation in a system catalyzed by
ferrous and ascorbate (Erickson and Hultin, 1992) .

5.3.2. Metal Chelating Activity
Metal chelating activity of carnosine was similar to imidazole with no significant
differences (p ≥0.05) at any concentrations tested (Table 5.1). Histidine did not exhibit
metal chelating activity while β-alanine exhibited detectable metal chelation at all
concentrations, however, these levels did not differ between levels (p ≥0.05). The data
collected revealed that carnosine exhibited metal chelation because of its imadazole ring
and not due to histidine, β-alanine or the presence of a peptide bond.
Carnosine acts as a metal chelator to retard oxidation reactions forming
complexes with copper ions, zinc, vanadium, Ni II and Mn II ions (Baran, 2000). The
protonated nitrogen (N3) in the imidazole ring interacts with Cu II ions and Zinc (Zn II)
and thus makes a stable metal complex (Chan and Decker., 1994), but it does not form a
complex with iron (Fe III) (Decker et al., 1992). However, the results of the current study
verify those of Kohen et al, (1988) that carnosine forms a complex with Fe2+ in the same
manner it does Cu2+. Thus, carnosine might stabilize feedstuffs against oxidation by
chelating Fe2+ and also as a carrier in diet to facilitate absorption.
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5.3.3. Free Radical Scavenging Activity
Free radical scavenging activity increased with concentration for carnosine and
histidine (p≤0.05) (Table 5.1), while β-alanine and imidazole showed slight to no
scavenging of free radicals (p ≥0.05).

Carnosine exhibited free radical scavenging

activity due to histidine and not due to imidazole ring present in its structure. These
results are in agreement with Wu et al. (2003). Kohen et al (1988) suggested that the
hydrogen’s on the methylene carbon next to the imidazole ring are the likely proton
donor terminating the oxidation reaction (Kohen et al, 1988) caused by free radicals. In
our study, data for free radical scavenging activity of histidine (at 25mM exhibited 4.48
% scavenging) was slightly lower than Wu et al (2003) (at 20mM exhibited 7.4%
scavenging). This difference was likely due to lower concentration of DPPH (0.1mM)
used by these authors compared to present study.
Oxygen radical scavenging capacity of carnosine, homocarnosine and anserine
against peroxyl radicals has been studied by Kohen et al. (1988) by using voltametric
measurements in AMVN {2, 2-azobis (2, 4-dimethylvaleronitrile)} and AAPH {2, 2’azobis (2-amidino-propane dihydrochloride)} systems under physiological conditions.
They also compared different structures such as carnosine, anserine, GABA {γ-amino
butyric acid}, imidazole, L-alanine, β-alanine and found that inhibition of

peroxyl

radicals by carnosine was 53%, histidine 42%, imidazole 39%, and anserine 39% while
GABA, L-alanine and β-alanine showed no inhibition. Inhibition against peroxyl radicals
is due to donation of a hydrogen atom to peroxyl radicals. Carnosine, histidine and β128

alanine results from Kohen et al (1988) were similar to the current study while those for
imidazole differed. The un-availability of electrons in the imidazole ring to donate to the
DPPH radical in the current study verses the availability of hydrogen atom to scavenge
peroxyl radicals used by Kohen et al (1988) may be the reason for differing results for the
imidazole.
Wu et al (2003) measured antioxidant activity of carnosine, anserine, histidine, βalanine, 1-methyl histidine and their combinations at different concentrations using a
ferric thiocyanate method to measure lipid autoxidation, DPPH radical scavenging assay
and Cu2+ chelating ability. They concluded that the peptide linkage in carnosine is
involved in its antioxidant activity. Similar conclusions were drawn by Chen and Decker
(1994) and supported that the antioxidant properties of carnosine could also be attributed
to the peptide bond present between β-alanine and histidine and not to histidine and βalanine alone. Similar conclusions were also drawn by Yen et al (2002).

5.4. Conclusions:
Based on the present study, the peptide bond may not contribute significantly to
antioxidant activity since the carnosine, histidine and imidazole exhibited antioxidant
ability in all tests while β-alanine didn’t show strong activity in any test conducted.
Therefore, it can be concluded that histidine and imidazole ring of histidine are important
for activity and not the peptide bond. Furthermore, these results were supported by
129

Kansci et al., (1997) who found that carnosine antioxidant activity is multifunctional and
it chelates metal ions, decreases free radicals and reacts with some secondary oxidation
products.
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Table 5.1: Antioxidant activities of carnosine and its constituents in different analysis.

TBARS Inhibition
(%)

Metal Chelating
Activity (%)

Free Radical
Scavenging Activity
(%)

1)
2)
3)
4)

Conc.

Carnosine

100mM

12.83 ± 1.15

50mM

11.21 ± 0.43

25mM

8.32 ± 0.92

5mM

0.42 ± 0.41

100mM

96.72 ± 1.31

50mM

96.44 ± 1.54

25mM

92.74 ± 3.38

5mM

86.56 ± 5.99

100mM

41.13 ± 12.40

50mM

25.16 ± 7.58

25mM

11.75 ± 3.54

5mM

1.86 ± 0.58

β-alanine

Histidine
e, f

g, f

g

14.70 ± 1.58
4.48± 0.41

i

g

18.80 ± 0.48

0± 0.00
a, b

a, b

a, b

b

b

d

a

c

d, e

h

0 ± 0.00
0 ± 0.00
0 ± 0.00

0± 0.00

d

i

4.62 ± 0.92
d

d

0.83 ± 0.38

18.44 ± 0.38
13.51 ± 0.23
10.42 ± 0.23
f

c

d

e

0.95±0.45
1.00±0.46

d

d

98.79 ± 0.37
96.92 ± 0.97
0.38± 0.14

h

0.71 ± 0.29

a

98.94 ± 0.40

h

0.59 ± 0.20

h

98.83 ± 0.37

d

0.82 ±0.21

c, d

16.28± 1.50

i

0.58 ± .20

d

b

24.53±2.04

0.36 ±0.11

d

a

32.84 ±1.14

i

0 ± 0.00

5.90 ± 0.22

i

0.05± 0.02

i

0 ± 0.00

0 ± 0.00

Imidazole

0.25± 0.09
h, g

h

0± 0.00

a

a

a, b

h, g

h

h

0 ± 0.00

h

TBARS Method; % Inhibition= {(MDA without extract-MDA with extract) / MDA without extract} x100
% Metal chelating activity= {1- absorbance of the sample at 562nm/ absorbance of control at 562nm} x 100
DPPH Assay; % Free radical scavenging = {(Absorbance of control– Absorbance of sample)/Absorbance of control } x 100
All values are Mean ± SEM (N=4); a, b values indicate within the column are significantly different (p ≤ 0.05) while a-i similar
letters indicate that the means values are not significantly different (p ≥ 0.05).
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CHAPTER SIX
EFFECT OF STRESS ON CARNOSINE LEVELS IN BRAIN, BREAST AND THIGH
OF BROILERS

Abstract
The objective of the present study was to measure carnosine levels in different
tissues of broilers under stress versus non-stress conditions. Heterophil-lymphocyte ratio
and corticosterone levels were measured as indicators of stress. Corticosterone levels of
stressed broilers (24358.67 pg/ml) were 10 folds higher (p=0.002) than non-stressed
broilers

(2275.46

pg/ml).

However,

there

was

no

difference

(p=0.29)

heterophil/lymphocyte ratio of non-stressed (0.29) and stressed birds (0.31).

in

Carnosine

content in breast of stressed birds (17.39 mg/gm) was 10 times higher (p=0.005) than
non-stressed birds (1.85 mg/gm). Carnosine content in thigh of stressed birds (21.25
mg/gm) was approximately 2 fold higher (p=0.001) than non-stressed birds (11.10
mg/gm). Carnosine content in brain of stressed birds did not differ (p=0.82) from that in
non-stressed birds. Based on the present study, carnosine may play significant role in
muscle function during short term stress.

Abbreviations: H/L ratio - Heterophil-Lymphocyte ratio
Keywords: Carnosine, Stress, Corticosterone, broilers

136

6.1. Introduction
Broilers face a multitude of stresses during feed restriction, catching, handling
and crating (Kannan and Mench, 1996; Nicol and Scott, 1990; Knowles and Broom,
1990), transportation ( Yue et al., 2010), shackling (Bedanova et al., 2007) and exposure
to heat (Altan et al., 2000) or cold (Campo et al., 2008; Maxwell, 1993) during housing
or transportation.
Numerous studies have been conducted elucidating the effects of stress on the
internal and external responses of chickens. The majority of research has indicated that
stress negatively affects meat quality. Transportation stress reduces the meat quality
(Pérez et al., 2002), reduces live weight (Kannan et al., 2000), reduces carcass weight and
nutritional quality (Tankson et al., 2001). Long term transport causes increase in breast
drip loss and affects the meat color (Yue et al., 2010) and results in smaller area and
higher density of type II fibers (Zhang et al., 2009). Pre-slaughter stress reduces initial
breast muscle pH, accelerates rigor mortis, decreases water holding capacity, increases
paleness (Northcutt et al., 1994; Tankson et al., 2001), and increases protein hydrolysis
(Dong et al., 2007). Thus, stress on chickens has been a major concern to the poultry
industry as stress can potentially lower the meat quality as well as reduce the customer
appeal.
There are multiple ways to measure stress in poultry including counting or
examining heterophil-lymphocyte ratio (H/L ratio) and measuring corticosterone levels
(Gross and Siegel, 1983). During stress, the levels of corticosterone increases, similarly
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heterophil lymphocyte ratio, which is 0.4 normally in broilers (Siegel and Gross, 2000)
increases with elevated stress in broilers (Gross and Siegel, 1983).
Carnosine is a natural water soluble dipeptide discovered from beef muscle in
1900 (Guelwitsch and Amiradgibi, 1900; Guelwitsch, 1906). On systematic analysis, it
was found that this dipeptide is composed of β-alanine and histidine. Out of these two
amino acids, histidine is an essential amino acid while β-alanine is a non-essential amino
acid synthesized in liver as a final product of uracil and thymine degradation (Matthews
and Traut, 1987).
Since its initial discovery, carnosine has been extracted from variety of animal
species and from different tissues in order to better understand the significance of
carnosine bodily functions. These studies have revealed that carnosine acts as
neurotransmitter in brain (Trombley et al., 2000; Tomonaga et al., 2004; Tomonaga et al.,
2005), as a buffer in the skeletal muscle (Davey, 1960; Skulachev, 2000; Smith, 1938), a
potent antioxidant in skeletal muscles(Chan and Decker, 1994; Kohen et al., 1988) and
aids in muscle contraction (Avena and Bowen, 1969; Severin et al., 1963). It also
regulates calcium proteins in cardiac muscles (Roberts and Zaloga, 2000), exhibits antiageing effect (Hipkiss, 1998; Hipkiss and Brownson, 2000; Reddy et al., 2005) and acts
as a chelating agent of metal ions (Baran, 2000; Chan and Decker, 1994; Kohen et al.,
1988).
It has been reported in the previous studies that injection of carnosine into the
brain of chicks induces hyperactivity and results in increase in blood plasma
corticosterone levels (Tomonaga et al., 2004; Tsuneyoshi et al., 2007; Tsuneyoshi et al.,
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2008). These studies found a relationship between carnosine and corticosterones and that
during stress conditions the levels of corticosterone increases in birds indicating that
carnosine may be a mitigating response to stress. Therefore, the objective of the present
study was to measure carnosine levels in different tissues of broilers under short term
stress versus non-stress conditions.

6.2. Materials and Methods

6.2.1. Materials
Sodium acetate trihydrate CAS# 6131-90-4, methanol- HPLC grade (0.2µm
filtered) CAS # 67-56-1, acetonitrile- HPLC grade (0.2µm filtered) [CAS # 75-05-8 ] and
ethyl acetate- CAS # 141-78-6 and EDTA-coated blood collection tubes (BD Vacutainer,
Lot # 9029222) were purchased from Fisher Scientific (Fair-lawn, New Jersey, USA).
OPA [phthaldialdehyde reagent; Product # 057K5015], L- carnosine [CAS # 305-84-0]
was purchased from Sigma Aldrich (Saint Louis, Missouri, USA). Macneal stain[Tetrachrome Stain- MacNeal; Catalog # 02783] was purchased from Polysciences. Inc
(Warrington, Pennsylvania, USA) while Corticosterone Enzyme Immunoassay KitCatalog#900-097 was purchased from Enzo Life Sciences (Plymouth Meeting,
Pennsylvania, USA).
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6.2.2. Treatment of birds
The total number of birds needed to perform the study was 20 and was determined
by using Power analysis program in SAS (Statistical Analytical Software, Edition 9.2) at
a 90% power level. Twenty (6-7 weeks old) birds were collected from different pens (10
for stressed and 10 for non-stressed treatment). For the stressed treatment, the birds were
held in the coops and driven in the back of a pick-up truck under sunny conditions for 15
min, followed by holding upside-down and wing flapping just before sacrificing. For the
non-stressed treatment group, birds were acclimatimated to handling by lifting and
holding them in the arms for approximately 3 min before sacrificing them. All birds were
sacrificed or euthanized by cutting the jugular vein and bled to death (this method was
used because the use of pentobarbital might potentially interfere with carnosine levels).
These procedures were conducted under the supervision of a animal use official.

6.2.3. Sample collection and Preparation
Blood samples were collected from the jugular vein immediately after
decapitation in EDTA-coated tubes and immediately stored in ice. After transport to the
lab (~2 hours), plasma was separated from the blood by centrifugation for 15 min at
5000 g in Sorval RC-5B refrigerated super speed centrifuge (Du-Pont Instruments,
Wilimgton, DE, USA) and supernatant (blood plasma) was collected in clean plastic
tubes, which were stored at -80°C until analysis.
For heterophil - lymphocyte ratio, blood smears were made from the collected
blood at the time of sacrificing and air dried at the collection site.
140

Breast, thigh and head samples were collected at the slaughtering site and kept in
ice during transport to the laboratory (~2 hours). Upon return to the laboratory, the brain
was removed from the head and stored under refrigeration (4±2°C).

6.2.4. Heterophill lymphocyte Ratio
Heterophill-lymphocyte ratios were determined by the staining method described
by Conn (1940) and George (1981), and cells were viewed using informative notes
provided by Glenn (2007). Smears were made by streaking a drop of blood over a clean
glass slide using a second slide or a cover glass. Streaked slides were air-dried quickly at
room temperature. Care was taken that the smears must be thin, preferably only one cell
thick. The prepared slides were stained by placing 1 ml of MacNeal’s Tetrachrome Stain
(B-152-1) on the smears for 1-3 min, followed by adding 2ml of phosphate buffer (pH
7.0) and keeping the slides for 5-6 min. After 5-6 min, the stains were flooded and
washed with phosphate buffer (pH 7.0) until thin portions of the smears were pink. The
smears were dry blotted carefully and after fixing with one drop of cytoseal-60, smears
were covered with cover slip and then observed under oil immersion lens (total
magnification 1000) (Carl Zeiss Microimaging GmbH, Munich, Germany).

6.2.5. Corticosterone Assay
The corticosterone levels were determined using corticosterone enzyme
immunoassay kit (Enzo Life Sciences catalog#900-097). Corticosterone from plasma was
extracted in chemical fume hood by adding 1ml ethyl acetate to every ml of sample. A
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total of three separate tubes for stress or non stress groups were made. The tubes were
vortexed and kept for ~ 45min and the upper organic layer was removed three times and
collected together in one tube. The collected organic layer was dried using gaseous
nitrogen (to remove ethyl acetate) and tubes were stored at -80°C until analysis.
The dried samples were reconstituted with 500µl assay buffer provided in the
enzyme immunoassay kit (Enzo Life Sciences catalog#900-097). Hundred microliter of
corticosterone standards (32, 160, 800, 4000, 20000 pg/ml) were added to the standard
wells while 100 µl samples were added to the sample wells and the protocol provided
with the manufacturers kit was followed. The 96-well plates were read at 405nm using
microplate reader Synergy-HT from BioTek Instruments, Inc (Winnooski, Vermont,
USA) and concentration of corticosterones were calculated using 4-parameter logistic
curve fitting program software KC4 provided with the equipment (BioTek Instruments
Inc., Winnooski, Vermont, USA).

6.2.6. Extraction of carnosine
Carnosine was extracted using a hot water extraction method described by
Maikhunthod et al., (2005) with slight modifications. In this method, to one part of meat
tissue, 2 parts of pre-cooled (4°C) nano pure water were mixed then homogenized for 3
min (2 times for 1.5min) in a blender (Ostersizer model # 4937, Sunbeam Products Inc.,
Boca Raton, Florida, USA) (for breast and thigh) and in Polytron® PT2100 homogenizer
(Capitol Scientific Inc., Austin, Texas, USA) for brain samples (different homogenizer
was used due to small amount of brain tissue as compared to breast and thigh). The
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homogenate was centrifuged at 20,000 g for 30 min at 4°C in Sorval RC-5B refrigerated
super speed centrifuge (Du-Pont Instruments, Wilimgton, DE, USA); then the
supernatant was filtered through Whatman #4 filter paper (GE Healthcare Bio-Sciences
Corp., Piscataway, New Jersey, USA). The water extracted filtrate (supernatant) was
subjected to a heat treatment at 80°C for 15min in water bath (Precision, Model#283,
Thermo scientific, Winchester, VA, USA) then immediately cooled in an ice bath,
followed by centrifugation to remove precipitated proteins at 6000 g for 20 min.
Supernatant was collected and stored at -80°C until further analysis.

6.2.7. Determination of carnosine by HPLC
Carnosine content in the tissue samples was determined using method described
by Gopalakrishanan et al. (1999) and Maikhunthod et al. (2005) with slight
modifications. Two ml of tissue sample extract was added to tubes containing 2 ml of
0.4M perchloric acid and vortexed with Vortex Genie 2

TM

(Model# G-560, Fisher

Scientific, Bohemia, New York) followed by boiling for 10 min (to precipitate proteins)
and then centrifuged at 5000 g for 5 min at 4°C in Sorval RC-5B refrigerated super speed
centrifuge (Du-Pont Instruments, Wilimgton, DE, USA). After centrifugation the
supernatant was filtered through 0.45µm membrane filter. Filtrate was derivatized using
OPA by adding 100 µl of OPA to 500 µl of sample, just prior to injection into HPLC
(Shimadzu Instruments, Columbia, MD, USA).
OPA derivatized carnosine was separated using a mobile phase of 0.3M sodium
acetate (pH 5.5), methanol and acetonitrile (75:15:10) at the flow rate of 0.75 ml/min on
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a Waters Spherisorb SCX-4.6x250 mm column (Waters Corporation, Milford, MA,
USA). Derivatized carnosine was detected using a fluorescence detector (RF551
Spectroflurometric detector, Shimadzu Instruments, Columbia, MD, USA) with
excitation wavelength of 310nm and emission wavelength of 375 nm. The standard curve
was prepared using a carnosine solution (5– 80 mM). The retention time and peak areas
were analyzed by EZ start 7.4 Software provided with the equipment (Shimadzu
Instruments, Columbia, MD, USA).

6.2.8. Calcium Content
Tissue sample extracts diluted 1:10 before measuring the mineral content. The
samples were sent to the Agricultural Services Laboratory at Clemson University where
the calcuim content was measured using inductively coupled plasma spectrometer
(SPECTRO ARCOS- ICP; Spectro Arcos, Kleve, Germany).

6.2.9. Statistical Analysis
Power analysis was performed to determine the number of birds to use in the
study. To perform the power analysis we used preliminary studies to estimate the true
mean difference in groups (15) and the standard deviation within the groups (10); and
then set the probability of Type I errors at 0.05 and Type II errors at 0.10. The power
analysis resulted in sample size of 20 birds to detect a difference of 15mM or greater with
standard deviation of 10 and a 0.05 chance of Type I error and 0.10 chance of a Type II
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error. SAS (Statistical Analysis Software, Edition 9.2) was used to perform the
calculations.
For Statistical analysis of the data, ANOVA was performed, to determine overall
differences in the group means while to determine specific differences between pairs of
group means, we performed Fisher LSD test. Both tests used a Type I Error rate of 0.05
and SAS (Statistical Analysis Software edition 9.2, SAS Institute Inc., 2007) was used to
perform the calculations.

6.3. Results
There was increase in plasma corticosterone levels in stressed compared to nonstressed birds. Corticosterone levels of stressed broilers was 10 fold higher (p=0.002)
than non-stressed broilers (Table 6.1) which indicated that the birds were stressed.
However, there was no difference (p=0.29) in heterophil/lymphocyte ratio between nonstressed (0.29) and stressed birds (0.31) (Table 6.1). The increase in corticosterone levels
in broilers as compared to heterophil - lymphocyte ratio was explained by Gross and
Siegel (1983) who stated that corticosterone levels are indicators of short term stress
while heterophil and lymphocytes are the indicators of longer term stress.
Stress increased the carnosine content in breast and thigh of birds, as compared to
the non-stress group, while there was no significant change in carnosine content in brain
of birds. Carnosine content in breast of stressed birds was 10 times higher (p=0.005) than
non-stressed birds breast (Table 6.2). Carnosine content in thigh of stressed birds was
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approximately 2 times higher (p=0.001) than non-stressed birds. However, carnosine
content in the brain of stressed birds did not differ (p=0.82) from non-stressed birds. Thus
there was a greater increase in breast and thigh carnosine and corticosterone levels
compared to levels of these compounds in the brain in response to short term stress
(Figure 6.1).

6.4. Discussion
There was no significant difference (p=0.29) in heterophil/lymphocyte ratio and
this lack of difference in heterophil/lymphocyte ratio of non-stress birds (0.29) and stress
birds (0.31) confirms previous work (Altan et al., 2000; Bedanova et al., 2007; Siegel and
Gross, 2000). These researchers found that the reason for a lack of change in the
heterophil lymphocyte ratio in reponse to short-term stress was the less time for
physiological change in these cells. Zulkifli (2000) and Gross (1990) indicated that any
change in heterophil lymphocyte ratio in response to stress would require at least 20
hours or more after stress.
Corticosterone levels for non-stressed chickens in the present study were slightly
higher (2275.46 pg/ml) than those reported by other researchers (Bedanova et al., 2007)
who studied stress in broilers at different time intervals during shackling. The reason for
the higher levels of corticosterones in the present study might be due to crating, ambient
disturbances as well unfamiliar personnel handlers for the broilers, which could induce
stress even among the non-stressed group of chickens (Knowles and Broom, 1990). The
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corticosterone levels in stressed chickens in the present experiment were similar to
corticosterone levels as measured by these same researchers.
Crating also causes increase in the corticosterone levels which could be a potent
stressor (Kannan and Mench, 1996). Moreover, it was concluded by Kannan and Mench
that upright handling is less stressful to the broilers than inverted handling (Kannan and
Mench, 1996; Kannan and Mench, 1997). However, rough inverted handling is practiced
in commercial facilities which augment the physiological stress among chickens (Kannan
and Mench, 1996; Kannan and Mench, 1997) . Increased corticosterone levels in stressed
compared to non stress broilers were in accordance with previous work (Bedanova et al.,
2007; Kannan and Mench, 1996; Kannan and Mench, 1997) and supports the conclusion
drawn by Gross and Siegel (1983) that corticosterone levels are the indicators of short
time stress while heterophil and lymphocytes are the indicators of long time stress.

6.4.1. Discussion of carnosine levels
Breast tissues are more susceptible to stress than thigh tissue (Lin et al., 2006). In
present study, the levels of carnosine found in breast and thigh muscles were higher than
the levels determined by Maitkhthund and Intarapichet (2005).

Maikhunthod and

Intarapichet (2005) reported carnosine levels of 2900.1 μg/gm for chicken breast muscle
and 419.9 μg/gm for thigh, about 7 times higher in breast compared to thigh muscle.
These researchers extracted carnosine at 60, 80, 100°C and with ultrafiltration (500 MW
cut off). We used hot water extraction (80°C for 15 min) instead of 80°C for 10 min or
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100°C for 10 min used by these authors, our treatment might improve the recovery of
carnosine from these tissues. Therefore, it is possible that this discrepancy arises due to
methodological differences, sample collection site and sample treatment differences in
birds. We found that with parallel increase in carnosine and corticosterone levels and
these results agree with previous authors who injected carnosine in the brain of chicks
and found increase in the levels of corticosterones (Tomonaga et al., 2004; Tsuneyoshi et
al., 2007).
Very little information is available on the effect of stress on carnosine levels and
the following discussion attempts to explain the reasons and mechanism behind carnosine
elevation during stress.

6.4.2. Carnosine increase might be due to protein degradation
During stress, protein synthesis decreases while protein catabolism rate increases
(Dong et al., 2007). It is likely that carnosine level is a by-product of protein hydrolysis
and certain enzymes are activated resulting in breakdown of proteins. Calpain I and
calpain II or (µ calpain or m calpain) are Ca-dependent proteases present in animal cells
and belong to the calpain family. In normal skeletal muscle, calpain and calpastatin are
located on or next to Z-disk with smaller amount on I-band (Goll et al., 2003). The
activity of µ/m calpain system is greater in breast and thigh (approximately 92%) than in
brain (72.9%) (Lee et al., 2007). During stress, corticoterone levels increase,
accompanied by proteolysis, which could be due to calpain system. Corticosterones are
known to increase muscle calpain activity (Hayashi et al., 2000), and we found that there
148

was an increase in calcium levels in muscles with stress (Table 6.2). There is a
relationship between calcium concentration with activation of µ or m calpain (Lee et al,
2007), and it is likely that µ calpain may be activated during stress. It was also reported
that µ calpain activity is greater in breast (8.9%) and thigh (6.6%) than in brain (1.1%)
(Lee et al., 2007) which may explain the greater change in carnosine levels in breast and
thigh compared to brain.

6.4.2. Carnosine relationship with creatine kinase
Corticosterone administration to chickens increases oxidative stress on cells
accompanied by increasing proteolysis and gluconeogensis (Gao et al., 2008) and in
increased plasma uric acid, and creatine kinase activity (Lin et al., 2004a and 2004b).
There is a possible relationship between creatine kinase and carnosine. Kannan et al.
(2000) reported that plasma creatine kinase activity peaked during transportation, and that
creatine kinase increased with corticosterone levels up to 2 hr after which these
compounds decreased. A study on exercised horses indicated that there is a direct
relationship between carnosine and creatine kinase during stress, that is, with an increase
in creatine kinase there is an increase in carnosine (Dunnett and Harris, 2002). In the
same study, they found an increase in plasma carnosine concentration after exercise from
5 to 30 min followed by a decrease in carnosine concentration at 120 min and this
concentration returned to normal level after one day (concentration after 24 hr was equal
to pre-exercise).

In comparison, during the present study with chickens, birds were

stressed for 15 min and it is possible that at this time carnosine was at peak levels due to
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stress in skeletal muscles which may decrease over time interval, as seen in exercised
horses. Therefore, more studies needed to be conducted at different time intervals to find
the exact correlation of carnosine with stress.

6.4.4. Formation of histamine from carnosine during stress
Flancbaum et al. (1990) suggested that carnosine plays crtitical role in histidine-histamine
metabolic pathways during stress. Carnosine acts as a reservoir for histidine (Flancbaum
et al., 1990a) which converts to histamine when demand arises during stress or injury
(Flancbaum et al., 1990b).

6.4.5. Relationship to Heat Shock proteins
During stress aggregated or misfolded proteins creates a large pool of non protein
substrates that compete with heat shock factors and carnosine may be one of them.
Released heat shock factor assembles to DNA trimmers and results in elevated
transcription, synthesis and accumulation of stress proteins. Known heat shock
transcription factors include salicylates, prostaglandins, arachidonic acid and amino acid
analogs which play roles in inflammatory responses (Morimoto, 1993).
It has been reported that zinc-carnosine induces HSP72 (heat shock protein72) in
gastric mucosa of rats (Odashima et al., 2002). NF-κB is a ubiquitous transcripition
factor which regulates transcription of many proinflammatory genes such as interleukin
(IL)-1β, IL-8 and tumor necrosis factor (TNF)-α. The same authors reported that along
with the induction of HSP72 protein, zinc-carnosine also suppresses NF-κB (Nuclear
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Factor- κB) activation and thus prevents mucosal injury and they suggested that zinccarnosine could be a potent chaperon (Odashima et al., 2006). Similar conclusions were
drawn by Mikami et al (2006),

in addition they also found that along with zinc-

carnosine, L-carnosine can also induce HSP72 (Mikami et al., 2006). Therefore, this
indicates that carnosine might facilitate expression of heat stress genes and induction of
stress shock proteins.
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Figure 6.2: Suggested possible Pathway
Stress

Increased proteolysis

Breakdown of proteins

Carnosine formed as byproduct of protein degradation

Histidine-Histamine Pathway
Carnosine might act as inducing factor for heat
shock proteins by combining with DNA

Heat shock or stress proteins formation
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6.5. Conclusions
The present study indicates that carnosine plays a significant role during stress.
Increase in carnosine levels in response to stress could be temporary and may reduce after
a certain time as the corticosterone levels return to normal approximately 3 hr after initial
stress. Additional research should be conducted to measure the carnosine levels at
different time intervals of stress in conjunction with corticosterone, creatine kinase,
carnosine synthetase activity, carnosinase activity, calpain activity etc. to better
understand and evaluate carnosine’s role during stress. There are few published reports
on the relationship of carnosine to stress. This study found a relationship between
carnosine, corticosterone and short term stress which was different between muscle and
brain tissues.
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TABLES and FIGURES

Table 6.1: Corticosterone levels and heterophil-lymphocyte ratio of stress and non stress broilers
Treatment Heterophil p(# of cells) values

1.
2.
3.
4.

Lymphocyte p(# of cells)
values

Non-stress

22.14±1.33 a

P=0.697 76.43±0.64a

Stress

23.11±1.69a

75.77±1.42a

Heterophil
pCorticosterone
Lymphocyte values Assay (pg/ml)
Ratio

P=0.661 0.29±0.018a
0.31±0.03a

P=0.59

2275.46±0.11a

P=0.002

24358.67±1.84b

Mean± S.E.M;
Total number of slides counted for heterophil- lymphocyte ratio was 10 and total # of cells counted per slide was 100.
For corticosterone assay (N=3)
Fisher’s Least Significant Difference Test was used to compare mean values; a-b similar letters indicate that the means
values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are significantly
different (p ≤ 0.05).
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Table 6.2: Carnosine levels in different tissues of stress and non-stress broilers.
Organ

Treatment

Breast

Non-stress

Calcium content
ppm
6.74±0.07 a

Stress

11.03±0.13 b

Non-stress

10.50±0.37 a

Stress

13.99±0.19 b

Non-stress

8.48±0.38 a

Stress

13.78±0.24 b

Thigh

Brain

p-value
P=0.001

Carnosine
Content (wb)2, 3
1.85±0.24 1, a

p-value
P=0.005

17.39±1.33b
P=0.006

11.10±1.02a

10.16±1.53a
10.27±2.77a

p-value
P=0.0005

70.89±5.39b
P=0.001

21.25±1.25b
P=0.002

Carnosine
Content (db)
7.52±0.97a

44.47±4.08a

P=0.002

85.12±5.01b
P=0.82

45.44±12.37a

P=0.54

55.12±14.88a

1. All values are in Mean± S.E.M (N=5)
2. wb= wet basis; db= dry basis
3. Carnosine content is expressed in mg/gm of the original sample.
4. Fisher’s Least Significant Difference Test was used to compare mean values; a-b similar letters indicate that the means
values are not significantly different (p ≥ 0.05); while different letters indicate that the mean values are significantly
different (p ≤ 0.05).
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Figure 6.1: Change in carnosine levels in different tissues during stress. Breast and thigh
carnosine levels were significantly different (p ≤ 0.05). Brain carnosine levels were not
significantly different (p ≥ 0.05).
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APPENDIX

Table 1A: (Stage 1) Extraction of Carnosine from organ samples (Mass Balance)
Organ

Sample wt.

Water Wt.

Other/Loss

Final
Extract

Tail

52.47±2.54

105±5

76.37±3.23

68.64±1.80

Gizzard

53.04±3.53

97.73±13.55

68.12±10.10

85.44±3.28

Liver

67.19±6.66

117.76±4.54

69.24±6.14

93.48±11.76

Head

55.12±5

110±10

79.82±9.79

85.04±1.87

Brain

62.64±2.20

113.52±7.93

68.13±0.77

90.26±12.71

Lungs

60.64±0.35

120.19±0.19

47.63±4.9

124.69±6.59

Heart

59.95±0.25

120±0

48.68±2.03

118.31±4.06

Mean± SEM (n =3)

All weights are in grams
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Table 2A: (Stage2) Ultrafilteration to purify extract (Mass Balance)
Organ

Extract wt.

Other/Loss

Final
Extract

Tail

40.17±9.79

5.94±2.23

34.22±7.59

Gizzard

27.76±0.33

1.26±0.175

26.49±0.50

Liver

30.94±1.11

1.08±0.51

29.85±0.62

Head

16.2±1.2

5.37±0.37

11.09±0.54

Brain

83.48±3.18

44.18±4.38

38.63±1.40

Lungs

30.02±0.42

4.24±0.89

25.77±1.81

Heart

29.56±0.33

2.52±0.43

27.04±0.13

Mean +SEM (n=3)
All weights are in grams
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Table 3A: (Stage3) Freeze drying (Mass Balance)
Organ

Ultrafiltrate initial wt Dry ultrafiltrate wt % Moisture % Dry solids

Tail

13.69±1.22

0.12±0.04

99.17±0.18

0.83±0.18

Gizzard 13.5±2.89

0.11±0.03

99.24±0.09

0.75±0.09

Liver

14.52±0.48

0.31±0.02

97.89±0.18

2.11±0.18

Head

19.46±0.05

0.11±0.01

99.45±0.08

0.54±0.08

Brain

15.01±0.26

0.12±0.02

99.42±0.09

0.76±0.09

Lungs

16.05±3.09

0.11±0.01

99.3±0.23

0.7±0.23

Heart

16.22±0.26

0.12±0

99.26±0.01

0.74±0.01

Mean ±SEM (n=3)
All weights are in grams
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Figure 1A: HPLC chromatogram of tissue ultrafiltrate- gizzard
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Figure 2A: HPLC chromatogram of tissue ultrafiltrate- heart
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Figure 3A: HPLC chromatogram of tissue ultrafiltrate- tail
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Figure 4A: HPLC chromatogram of tissue ultrafiltrate- head
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Figure 5A: HPLC chromatogram of tissue ultrafiltrate- brain
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Figure 6A: HPLC chromatogram of tissue ultrafiltrate- liver-1:15 dilutions
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Figure 7A: HPLC chromatogram of tissue ultrafiltrate- lungs
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Figure 8A: HPLC chromatogram of organ ultrafiltrate- liver-1:15 dilutions spiked
with histidine, anserine and carnosine (1:1:1 ratio)
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Figure 9A: HPLC chromatogram of reconstituted gizzard dry powder (25mg/ml)
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Figure 10A: HPLC chromatogram of reconstituted heart dry powder (25mg/ml)
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Figure 11A: HPLC chromatogram of reconstituted brain dry powder (25mg/ml)
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Figure 12A: HPLC chromatogram of reconstituted liver dry powder (25mg/ml)
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Figure 13A: HPLC chromatogram of reconstituted tail dry powder (25mg/ml)
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Figure 14A: HPLC chromatogram of reconstituted lungs dry powder (25mg/ml)
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Figure15A: HPLC chromatogram of reconstituted head dry powder (25mg/ml)
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Figure 16A: HPLC chromatogram of Poultry protein meal- sample-A
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Figure 17A: HPLC chromatogram of Poultry protein meal- sample-A spike
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Figure 18A: HPLC chromatogram of Poultry protein meal- sample-G
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Figure 19A: HPLC chromatogram of Poultry protein meal- sample-G- spike
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Figure 20A: HPLC chromatogram of carnosine standards at different
concentrations.
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Figure 21A: HPLC chromatogram of breast-non stress sample
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Figure 22A: HPLC chromatogram of breast-stress sample
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Figure 23A: HPLC chromatogram of thigh-non stress sample
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Figure 24A: HPLC chromatogram of thigh-stress sample
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Figure 25A: HPLC chromatogram of brain-non stress sample
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Figure 26A: HPLC chromatogram of brain-stress sample
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